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lab. Thanks to Dr. Jun Yan for picking me up on the first day I came to Knoxville. His
humor and wisdom really supported a rookie back then. Dr. Gao Chen is a better literature
search engine than Google Scholar, so I wish to thank him for passing on his knowledge
and understanding about microbiology. I thank Amanda for introducing me to the mass
spectrometry world and Patrick Mahomes. Thanks also go to Cindy Swift, Dr. Fadime
Kara-Murdoch, Dr. Robert W. Murdoch, Dr. Yongchao Yin, Dr. Briana McDowell,
Yanchen Sun, Guang He and Diana Ramirez, for all their kind help and support. The
working and studying experience with them over the past five years has been unforgettable.
The love and companionship of my friends have supported me through all
difficulties, and even through the pandemic. I have really appreciated taking this journey
with them.
iv

Finally, I want to thank my parents, whose unconditional love has made me bright
and brave.

v

ABSTRACT
Fluorinated organics have been developed and produced for various applications in
the industrial, military, medical and agrochemical fields; they are now emerging as
persistent organic pollutants with demonstrated adverse health impacts on mammals,
including humans. The high bond dissociation energy of C-F bond hinders microbial
degradation and defluorination. The present work demonstrates Pseudomonas sp. strain
273 can utilize the 1-fluoroalkanes (C7 to C10 and C14) and 1,10-difluorodecane (DFD) as
the sole carbon source in the presence of oxygen. In this study, fluorine mass balance
analysis determined that the majority (> 90%) of the fluorine from the fluoroalkanes could
be recovered as inorganic fluoride. Short-chain fluorinated fatty acids were detected as the
degradation products in β-oxidation. Notably, metabolome analysis indicated that a meager
portion of fluorinated intermediates (e.g., short-chain fluorinated fatty acids) could be
channeled into anabolism in producing long-chain fluorinated fatty acids and fluorinated
glycerophospholipids. In the cells of strain 273 grown with DFD, more than 90% of the
glycerophospholipids were fluorinated. The covalent incorporation of fluorine into
anabolic products was unraveled as a novel sink for fluorine, potentially and significantly
impacting the fate and transport behavior of fluorinated organics in the environment. This
study proposes a detailed fluoroalkane metabolism pathway and identifies defluorinating
enzymes in strain 273 based on the collective metabolomic, genomic, and transcriptomic
evidence. Two enzyme systems containing alkane 1-monooxygenase (Gene ID:
2814128504) and (S)-2-haloacid dehalogenase (2814128232), respectively, were
upregulated in cells grown with DFD, which might be associated with defluorination of the
DFD. The investigation of the fluoroalkanes metabolism in strain 273 using multi-omics
approaches advances the understanding of fluorinated organics’ metabolic behavior in both
catabolic and anabolic directions and can assist in the development of biodegradation,
biosynthesis, and remediation strategies for fluorinated organics.

Keywords: Defluorination, fluoroalkanes, Pseudomonas, fluorine assimilation.
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Chapter 1. Introduction
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1.1 Occurrence and degradation of fluorinated organics in the environment
1.1.1 Natural and anthropogenic production of fluorinated organics
1.1.1.1 Naturally occurring fluorinated organics
Fluorine ranks as the 13th most abundant element in the terrestrial environment, with about
270 to 740 ppm (mg/kg) present in sedimentary rocks compared to about 10 to 320 ppm of
chlorine.1 However, only tens of fluorinated chemicals have been found with biological origins
while thousands of naturally occurring halogenated compounds have been discovered so far.2, 3
The scarcity of fluorinated organics may be explained by several reasons. First, fluoride
concentration is low in a water environment such as ocean water, at 1.4 ppm in comparison to
chloride at 19,000 ppm and bromide at 65 ppm.1 Second, fluorine is difficult to be incorporated
into biomolecules since its extremely strong electronegativity and high redox potential. One
pathway of biomolecule halogenation is catalyzed by haloperoxidase enzymes that incorporate the
halogen into biomolecules via the generation of halonium ions (X +) or halide radicals (X•)
mediated by the hydrogen peroxide produced. The standard redox potential (E0’) of
oxidant/reductant follows the order of F2(g) / F-(eq) (+2.87 V) > H2O2(eq) / H2O(eq) (+1.78 V) >
Cl2(g) / Cl-(eq)(+1.36 V) > Br2 (eq)/ Br-(eq)(+ 1.09 V) > I2(s) / I-(eq) (+0.54 V) indicating that
biomolecule halogenation mediated by hydrogen peroxide is exceptionally thermodynamically
unfavorable in the case of fluorine.4
Among thousands of biologically occurring halogenated compounds, only a few
fluorinated chemicals, including fluoroacetate, fluorocitrate, fluoroacetone, -fluorofatty acids,
nucleocidin, 4-fluorothreonine and 5-fluoro-2,3,4-trihydroxypentanoic acid, have been reported
with biological origins (Figure 1.1).3, 5, 6 There has been no observation of de novo organofluorine
production in the animal kingdom or from any organism in the marine environment.7 Natural
biological production of organofluorine incorporating inorganic fluoride has only been identified
in a small subset of plants and microorganism species in the Actinomycetes class. Potassium
fluoroacetate was discovered in the poisonous plant Dichapetalum cymosum as the first known
naturally occurring organofluorine in 1943.8 The abundance of fluorine is distributed
disproportionally among tissues and species in organofluorine producing plants. About 455 µg of
fluorine per gram of leaf (dry weight) was measured in Palicourea margravii, and 1,980 µg of
fluorine per gram of seed (dry weight) was measured in Dichapetalum toxicarium.9 The major
organofluorine products in these plants were determined as fluoroacetate and long-chain -
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fluorofatty acids which compose the cuticle in leaf and seed serving as a defense barrier against
virus and bacteria infection.7, 10 Notably, fluoroacetate has been applied as a toxin for animals (e.g.,
sodium fluoroacetate) with the function of inhibiting aconitase and consequently resulted in the
disorder of the tricarboxylic acid cycle. The lethal metabolism was observed in a rat consuming
the long-chain ω-fluorofatty acid followed by the generation of fluoroacetate from β-oxidation.11
In the soil around the root of D. toxicarium, a high concentration of organofluorine has been
measured at 134 µg of fluoroacetate per gram of soil (dry weight).12 In the case of prokaryote, the
first discovery of organofluorine produced by bacteria was the nucleocidin with the formula
C10H13FN6O6S from Streptomyces calvus as an antibiotic affecting trypanosomes.13 The 5’-fluoro5’-deoxyadenosine

synthase,

which

incorporates

inorganic

fluoride

into

5-fluoro-5-

deoxyadenosine in Streptomyces cattleya, was characterized in 2002.14 Other fluorinated
metabolites, including fluoroacetate and 4-fluorothreonine, both derived from 5-fluoro-5deoxyadenosine, have also been discovered in Streptomyces spp.15, 16
Besides those of biological origin, geologic sources of fluorinated organic have also been
identified, including volcanic sources and emissions from well-drilling.1 Fluorinated organics,
including fluorotrichloromethane (up to 1 ppb, by volume), trifluoropropene, fluorobenzene,
tetrafluorobenzene and fluorochlorobenzene have been detected in fumaroles and lava gas
collected from volcanoes around the world. However, the emission of chlorofluorocarbons (CFCs)
from volcanic origin is estimated to be negligible compared to anthropogenic emission sources.17
The clear evidence that geologic and biological systems generate C-F bonds implies that
fluorinated organics have long been part of the biosphere, and that microorganisms have had ample
time to evolve strategies for breaking C-F bonds.

1.1.1.2 Anthropogenic production of fluorinated organics and the environmental impacts
Fluorinated organics have been extensively produced and applied in industrial, medical,
and commercial goods due to their advantageous properties, including water- and oil- repellence,
thermo-resistance, etc. For example, CFCs, the major component of Freon, have been widely
utilized as refrigerants in refrigerators and air conditioners because of their desirable
thermodynamic properties. Furthermore, a profile of per- or polyfluoroalkyl substances (PFAS)
(Figure 1.1) has been designed and applied in the past eight decades with applications in nonstick
cookware, water and oil-repellent apparel, lubricants, fire-resistance insulation, and firefighting
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foams, etc. No less than 478 different kinds of PFAS have been developed and applied in U.S.
commerce;

perfluorooctanoic

acid

(PFOA),

perfluorononanoic

acid

(PFNA)

and

perfluorooctanesulfonic acid (PFOS) are legacy products which had been phased out of production
from companies committed to a stewardship program in 2015.18 In 2006, PFOS was listed as a
persistent organic pollutant under Annex B of the Stockholm Convention with the goal of
enhancing environmental regulation and restricting global production of PFAS. However, the newfound alternative PFAS, including GenX and perfluorobutanesulfonic acid (PFBS), are now being
produced and applied, which emerged as new environmental concerns.
Fluorinated chemical emissions in global history have resulted in their ubiquitous
distribution in aquatic, terrestrial and atmospheric environments with adverse effects on both the
environment and public health. A variety of environmental science studies detected that PFAS
have been released and transported to water, soil, and air environments in long-range and
demonstrated global distribution. For example, over 40 classes of PFAS have been identified in
groundwater samples collected from military bases across the U.S.A. in which had PFAScontaining aqueous film-forming foams (AFFFs) application history.19 Tens to hundreds ng/L of
PFOS and PFOA have been detected in drinking water in studies of different regions, including
Asia, Europe, and Africa.20 Moreover, PFAS can be detected in seemingly pristine environment.
From 11 to 174 pg/L of PFAS were quantified in surface water in the central Arctic ocean, it has
been estimated that 2 to 12 tons of PFAS are introduced into the Arctic per year by oceanic
transport.21, 22
Widespread fluorinated organics such as CFCs and PFAS are considered to be
environmental risks. For example, chlorine radicals dissociated from the CFCs in the stratosphere
can substantially accelerate the ozone depletion.23 Adverse health impacts have been determined
in various toxicological studies, in which fluorinated chemicals, in particular PFAS, demonstrate
high bioaccumulation potential and cause the detrimental influences on the immune system and
reproductive function in mammals.24-26
Fluorinated organics raise both environmental and public health concerns as emerging
contaminants. Scientific communities are looking for effective remediation strategies with high
treatability.
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1.1.2 Physical, chemical and biological approaches to degrade fluorinated organics
An extensive body of literature has developed since the emergence of fluorinated pollutants;
physical, chemical and biological studies aimed at cleaning and degrading fluorinated organics
both in situ and ex situ have been published. Adsorption to granular activated carbon (GAC) is
commonly applied removal strategy for PFAS in groundwater environments, showing over 90%
removal efficiency followed by complete decomposition using high-temperature incineration.27 To
improve performance and limit cost, optimized adsorption biomaterials have been developed,
including bamboo-derived GAC and cross-linked chitosan beads, both of which have
demonstrated higher adsorption capacity.28, 29 Moreover, sonolysis of PFAS with the concomitant
generation of shorter-chain products has been observed under ultrasound treatment.30 Under an
irradiation frequency of 358 kHz, about 39% and 44% of PFOS and PFOA, respectively, were
degraded at an initial concentration of 200 µM.31 Other oxidation technologies mediated by
activated persulfate, peroxide, high valent iron, etc., have been reported to degrade PFAS.32, 33
Both superoxide (O2-) and hydroperoxide (HO2-) anions generated in H2O2 propagation reactions
have been shown to be able to degrade 68% and 80% of PFOA in 150 minutes with the recovery
of near-stoichiometric equivalents of fluoride, indicating the complete mineralization of PFAS in
the degradation process.34 On the other hand, reductive dehalogenation on fluorinated organics has
also been demonstrated in multiple reaction systems that contained zero valent iron, hydrated
electrons, or a mixture of vitamin B12 and titanium (Ti(III)) citrate.35, 36 The cobalt complex in
vitamin B12 can play a role as an electron shuttle in transferring electrons from more reduced
molecules, such as titanium citrate, to more oxidized molecules of PFAS, resulting in a reductive
defluorination reaction with concomitant fluoride release.37,

38

For this reaction, the optimal

condition was determined to be pH = 9 and temperature = 70°C.39
Microbial degradation on fluorinated organics will be discussed in Section 1.2 in detail.
However, the above-mentioned laboratory discoveries of defluorination activity are sometimes
conducted in the extreme pH and temperature conditions which may not be relevant to practical
environmental conditions. The treatment chain, which is composed of multiple treatment
approaches to synergistically eliminate fluorinated organics, adapted to practical circumstances,
may overcome the application barrier. A novel clean-up approach for fluorinated organics is fully
expected.
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1.1.3 Recalcitrance of C-F bond
1.1.3.1 High bond dissociation energy of C-F bond
Fluorine has the smallest Van der Waal’s radius (1.47 Å) of the halogen atoms, with
electron orbit distribution at 1s22s22p5.40 On the other hand, fluorine demonstrates the highest
electronegativity (at 3.98 in Pauling scale) of all the elements discovered so far, which results in
extensive electron-withdrawing ability of fluorine in the associated covalent bonds.41 The C-F
bond would be less covalent and more electrostatic resulting from the polarized Cδ+ and Fδ- atoms
and the electrostatic stabilization would hinder the release of free fluoride in the defluorination
reaction.42 The bond dissociation energy of carbon-halogen bonds in methyl halides follows this
order: CH3-F (110 kcal/mol) > CH3-Cl (83.7 kcal/mol) > CH3-Br (70.3 kcal/mol) > CH3-I (54.0
kcal/mol), indicating that the C-F bond is more stable and more difficult to break than other carbonhalogen bonds.43 In the case of multi-fluorinated ethane, the increased number of fluorine
substitutions may strengthen the C-C bond and C-F bond in the molecule. For example, the C-C
bond dissociation energy (kJ/mol) in ethane (375.5) is lower than that in 1,1,1-trifluoroethane
(423.9). And the C-F bond dissociation energy (kJ/mol) in 1,1-difluoro-2-fluoroethane (458.4) is
lower than that in 1,1,-difluoro-2,2-difluoroethane (518.2).44 In terms of PFAS, both experimental
results and computational analyses have demonstrated that the bond dissociation energy follows
this order: tertiary C-F bonds < secondary C-F bonds < primary C-F bonds, suggesting that the
terminal tertiary C-F bonds is an ideal initiating position for a defluorination reaction.38 The perand polyfluorinated structure confers high stability and recalcitrance of the fluorinated organics.

1.1.3.2 Persistence of fluorinated organics in the environment
CFCs have been applied as refrigerants and emitted primarily into the atmospheric
environment with severe adverse effects on the ozone layer. Stratospheric photodissociation is
considered to be a major atmospheric sink for CFC.45 The atmospheric lifetime of CFC could be
up to hundreds of years, and the duration time of fluoroforms (HFC-23, CHF3) and
dichlorodifluoromethanes (CFC-12, CF2Cl2) has been estimated at 400 and 104 years,
respectively.46 In the case of PFAS, the half-life time of PFOS and PFOA in the atmospheric
environment has been determined to be 114 days and 80 days, respectively. However, the extended
half-life time has been determined to be over 41 years and over 92 years, respectively, in a water
environment.27
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Fluorinated organics are considered “forever chemicals,” exhibiting recalcitrance and
extremely long lifetimes in the environment. The inherent recalcitrance and stability of the
molecules both derive from the strength of the C-F bonds, which hinder the degradation and
transformation of fluorinated organics in the environment.

1.2 Microbial cleavage of C-F bonds in fluorinated organics
1.2.1 Microorganisms release fluoride from fluorinated fatty acids
Fluoroacetate is one of the most common naturally occurring fluorinated organics, and
defluorination of fluoroacetate have been demonstrated in various bacterial and fungal
microorganisms. Fluoride release from fluoroacetate was first reported in microbial cell extracts
in 1962.47 Subsequently, enzymatic defluorination on fluoroacetate with the generation of fluoride
and glycolate was determined in pseudomonad soil isolate.48 The defluorination of fluoroacetate
was also determined in bacteria, including Pseudomonas spp., Moraxella sp. strain B,
Burkholderia sp. strain FA1, Pigmentiphaga kullae, Ancylobacter dichloromethanicus, and fungi
Fusarium solani, etc.49-51 Moraxella sp. strain B is able to grow with fluoroacetate as the sole
carbon source, and one fluoroacetate dehalogenase homolog protein, purified from the strain B,
predominantly acted on fluoroacetate, demonstrating 20-fold higher activity than chloroacetate or
bromoacetate.50 Anaerobic defluorination on fluoroacetate has been discovered in bovine rumen
bacterium Synergistetes sp. strain MFA1 under an amino acid fermenting condition.52 Growth
yield was stimulated in the presence of fluoroacetate, suggesting that strain MFA1 possibly gained
energy from the reductive defluorination of fluoroacetate. However, trifluoroacetate and
chloroacetate could not be degraded by strain MFA1 under the same growth condition.
Trifluoroacetate could be released into the atmospheric environment as the oxidation product of
CFC. Microbial degradation of trifluoroacetate has been observed in microcosms enriched under
both oxic and anoxic conditions.53 The

14C-isotope

experiment indicated that the stepwise

reductive defluorination of trifluoroacetate occurring in saltmarsh sediment enrichment , which is
supported

by

the

detection

of

2-14C-trifluoroacetate,

2-14C-difluoroacetate,

2-14C-

monofluoroacetate, 2-14C-acetate and 14C-methane.54
Furthermore, defluorination of fluorinated fatty acids, including 3-fluoropyruvate, 2fluoro-maleylacetate etc., has also been discovered in microbial activities.55,

56

For example,

7

purified pyruvate dehydrogenase form Escherichia coli can decompose the fluoropyruvate to
acetate and fluoride mediated by thiamine pyrophosphate.57
1.2.2 Microorganisms release fluoride from fluorinated aromatics
As an environmental hazardous contaminant, degradation and defluorination of
fluoroaromatics have been reported in a variety of microbiology studies. Fluorobenzoate has been
the most studied fluorinated aromatic for biodegradation. Pseudomonas sp. is able to utilize 2fluorobenzoic acid as the sole carbon source and release fluoride in the presence of oxygen. An
18O-isotope

experiment indicated that catechol is generated from 2-fluorobenzoic acid by

incorporating two oxygen atoms derived from the single molecule of oxygen.58 Pseudomonas sp.
strain T-12 can degrade a broad range of 3-fluoro-substituted benzenes aerobically, including 3fluorotoluene, 3-fluorotriefluorotoluene and 3-fluoroanisole, with the concomitant release of
fluoride.59 An interesting observation was made in Aureobacterium sp. strain RHO25 isolated from
water and soil samples in the Stuttgart area. Strain RHO25 could grow in a medium supplied with
benzoate and 4-fluorobenzoate as the sole carbon source but not with 4-chlorobenzoate, indicating
that the enzyme might evolve specifically to 4-fluorobenzoate degradation.60 4-Fluorophenol can
serve as the sole carbon and energy source for the growth of Arthrobacter sp. strain IF1. In addition,
the gene expression study utilizing Northern blotting and reverse transcription-PCR approaches,
has demonstrated that monooxygenase system might be involved in transforming 4-fluorophenol
into hydroquinone.61 Anaerobic degradation on fluorinated aromatics was recently reported in
Thauera aromatica. The complete degradation of 4-fluorobenzoate, 4-fluorotoluene and 2fluorobenzoate to CO2 and fluoride was observed in the culture of Thauera aromatica using nitrate
as the electron acceptor under anoxic condition.62, 63 Fluorobenzene degradation has been observed
in pure culture of Rhizobiales strain F, which was later classified as Labrys portucalensis sp. strain
F11.64, 65

1.2.3 Microorganisms release fluoride from fluorinated alkanes
CFCs are a class of short-chain fluorinated aliphatics with one or more chlorine and
fluorine substituent(s). CFCs degradation have been observed in microorganisms in both oxic and
anoxic conditions. The methanotrophic-linked degradation of dichlorofluoromethane (HCFC-21,
CHCl2F) occurred in soil samples collected from agricultural fields located in the Sacramento
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River delta in California.66 A methanotrophic enrichment, mixed culture MM1 demonstrated
degradation

capability

to

chlorodifluoromethane

(HCFC-22,

CHClF2),

1-chloro-1,1-

difluoroethane (HCFC-142b, CH2ClCHF2), 1,1,1,2-tetrafluoroethane (HFC-134a, CH2FCF3) and
2,2-dichloro-1,1,1-trifluoroethane (HCFC-123, CHCl2CF3) following the order of decreasing
reactivity, while the defluorination activity was not mentioned.67 The defluorination of
dichlorofluoromethane (HCFC-21, CHCl2F) was observed in pure culture of methanotrophic
bacterium Methylosinus trichosporium OB3b. The degradation and defluorination of HCFC-21
could be inhibited by the addition of acetylene, suggesting the possible involvement of the soluble
methane monooxygenase.68 Under anoxic condition, the homoacetogenic bacterium Sporomusa
ovata strain H1 can cleave C-Cl and C-F bonds from 1,1,2-trichloro-1,2,2-trifluoroethane (CFC113, CCl2FCClF2) mediated by reducing equivalent as corrinoid.69
However, few studies have reported that microorganisms can grow with or degrade
medium-chain or long-chain fluorinated alkanes. Bacteria that can utilize chloroalkane usually
cannot utilize fluoroalkane, presumably due to the stronger strength of the C-F bond than that of
the C-Cl bond. For instance, a wide spectrum of halogenated alkanes, including medium-chain
chloroalkanes and bromoalkanes, can be degraded by Pseudomonas strain ES-2, while 1fluorohexane and 1-fluorononane cannot.70 Arthrobacter sp. strain HA1 is able to grow with 18
different C2 to C6 1-chloro-, 1-bromo-, and 1-iodoalkanes as the sole carbon source with a resultant
release of stoichiometric amount of halide. But neither growth nor dehalogenation was observed
in the culture supplied with 1-fluoropentane.71
Bacterial degradation of medium-chain and long-chain fluorinated alkanes stays elusive
and has raised increasing research interest from the bioremediation perspective.

1.2.4 Microorganisms release fluoride from PFAS
PFAS have been extensively produced and applied in industrial, medical and commercial
products. Polyfluoroalkyl substances which contain a moiety of -(CH2)n- have been shown to be
susceptible to microbial degradation and considered as the precursor to perfluoroalkyl substances
in the environment.72 To search for microorganisms capable of breaking C-F bonds in PFAS,
activated sludge from wastewater treatment plants (WWTPs) and soil samples from PFAS
contaminated sites have been commonly selected sources for laboratory PFAS degradation
enrichment. Aerobic degradation of 1H,1H,2H,2H-perfluoro-1-decanol (8:2 fluorotelomer alcohol)
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has been observed in soil samples with half-life as short as 7 days. However, the conversion rate
of the 8:2 fluorotelomer to PFOA, varies from 10% to 40% among soils with different types and
origins.73 Microcosms enriched from a firefighter training area contaminated by PFAS were
capable of degrading 4:2, 6:2, and 8:2 fluorotelomer thioether amido sulfonate (FtTAoS)
aerobically with the generation of C4 to C8 perfluorinated carboxylic acids as the biotransformation
products.74 Meanwhile, anaerobic biotransformation of 6:2 FtTAoS to 6:2 fluorotelomer thioether
propionate (6:2 FtTP) was also observed under sulphate-reducing condition in microcosms
inoculated by both pristine and AFFF-impacted soils.75 However, 6:2 FtTP was recalcitrant to
further degradation under this cultivation. Biotransformation of 6:2 fluorotelomer alcohol to
incomplete degradation products has also been discovered in pure cultures of bacteria species,
including Mycobacterium vaccae JOB5, Pseudomonas oleovorans, Pseudomonas butanovora,
Pseudomonas fluorescens DSM 8341 etc., and the fungal species Phanerochaete chrysosporium.76,
77

The recalcitrance of PFAS in the environment cannot be resolved by the biotransformation
of fluorotelomers into perfluorinated products with a shorter chain length. The recovery of fluoride
in PFAS degradation should provide direct evidence for the occurrence of defluorination. However,
much less literature has reported the recovery of fluoride from PFAS degradation conducted by
microorganisms. Pseudomonas sp. strain D2 can utilize difluoromethane sulfonate (DFMS),
trifluoroethane sulfonate (TES) and 1H,1H,2H,2H-perfluorooctane sulfonate (H-PFOS) as sole
sulfur source, but did not utilize trifluoromethane sulfonate (TFMS) or PFOS. Complete
degradation of DFMS and release of a stoichiometric amount of fluoride has been observed in
culture of strain D2 after 50 hours of incubation. However, partial defluorination of H-PFOS was
determined by recovering 1.42 ± 0.04 mol of fluoride from each mole of H-PFOS supplied.78 A
recent publication demonstrated that a newly isolated bacterium, Acidimicrobium sp. strain A6,
can release fluorine as fluoride from perfluorinated chemicals, including PFOA and PFOS, under
ferric iron reduction coupled with ammonia oxidation or hydrogen oxidation at pH around 5.79
According to the high oxidation state of the per- and polyfluorinated molecule, PFAS are
considered as possible electron acceptors to provide energy for organohalide-respiring bacteria.
One recent study suggested that two kinds of PFAS, perfluoro(4-methylpent-2-enoic acid) and
4,5,5,5-tetrafluoro-4-(trifluoromethyl)-2-pentenoic acid could serve as the sole electron acceptor
in trichloroethylene dechlorinating consortium KB1 with the release of fluoride observed.80
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1.3 Enzymes involved in defluorination
1.3.1 Hydrolytic defluorination
Hydrolytic defluorination of fluoroacetate has been determined in a group of cytosolic
proteins from multiple microorganisms. Two dehalogenase encoding genes were identified in
plasmid from Moraxella sp. strain B and designated as dehH1and dehH2, respectively. The size
difference (885 bp and 675 bp) and low sequence similarity revealed no homology between the
two genes.81 The dehH1 has been determined as fluoroacetate dehalogenase gene belongs to the
α/β hydrolase superfamily and the dehH2 has been determined as (S)-2-haloacid dehalogenase
gene belongs to the haloacid dehalogenase-like hydrolase superfamily. The substrate range is
different in the two enzymes. The DehH1 acts predominantly on fluoroacetate while DehH2 acts
on chloro-, bromo- and iodoacetate, but not on fluoroacetate.81 Based on the predicted functions
according to their nucleotide sequences, over a hundred genes encoding dehalogenase-like proteins
from both the α/β hydrolase superfamily and the haloacid dehalogenase-like hydrolase superfamily
were selected and the dehalogenation activity was tested using heterologous expression in
Escherichia coli. Only 7 out of 113 proteins tested shown dehalogenation activity while the
majority of proteins were tested as esterases and phosphatases, suggesting low sequence
conservation and high sequence diversity among dehalogenating enzymes. It is noteworthy that
four novel (S)-2-haloacid dehalogenases were demonstrated to hydrolyze fluoroacetate, which was
the first discovery of proteins belonging to haloacid dehalogenase-like hydrolase superfamily with
such activity.82 A high-resolution (1.15-1.80 Å) crystal structure of a fluoroacetate dehalogenase
from Rhodopseudomonas palustris CGA009 suggested that the selectivity on fluorinated substrate
was derived from the halide binding pocket of the enzyme, which supplies three hydrogen bonds
to stabilize the fluoride and is tailored to the sterically smaller fluorine atom.83 Fluoroacetate
dehalogenase from Burkholderia sp. strain FA1 was illustrated as a homodimer harboring two
subunits, each consisting of core and cap domains. Site-directed mutation on active-site residue
Trp150 resulted in complete loss of activity toward fluoroacetate, but not toward chloroacetate,
indicating that the enzyme pocket configuration is crucial to C-F bond cleavage.84 Other hydrolytic
enzymes acting on fluoroacetate were also found in Pseudomonas and Delftia, etc..85
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1.3.2 Oxidative defluorination
Because oxygenases conditionally bind to cellular membranes and need multiple
components to complete the electron transfer to the co-substrate in the oxidation reaction, the
enzymatic oxidative defluorination is mostly speculative based on the experimental evidence,
including oxygen dependence, oxidation intermediate detection and gene expression analysis. For
example, the oxygen-dependent defluorination on 4-fluorobenzene has been demonstrated in
Rhizobiales strain F11 (later classified as Labrys portucalensis sp. strain F11) possessing
fluorobenzene dioxygenase. Catechol and 4-fluorocatechol were both measured as products
generated in the first step oxidation of 4-fluorobezene, resulting from the difference of initial
oxidation points by fluorobenzene dioxygenase. Unstable intermediates 1-fluoro-cis-benzene-1,2dihydrodiol are generated, followed by spontaneous intramolecular elimination with resultant
fluoride release and catechol production. This step was considered to be nonenzymatic
defluorination.65 A similar defluorination mechanism has also been found in Pseudomonas sp.
strain T-12 in that 3-fluorotoluene is oxidized by toluene-2,3-dixoxygenase, resulting in fluoride
release.59
Resting cell experiment demonstrated the aerobic defluorination of dichlorofluoromethane
(HCFC-21) occurring in dense cell suspension of Methylosinus trichosporium OB3b grown with
methane, which had methane monooxygenase induced. However, the defluorination activity was
absent in dense cell suspension grown with methanol or with the addition of acetylene, a methane
monooxygenase inhibitor. These collective observations indicate that methane monooxygenase is
involved in CFC defluorination.68
Oxidative defluorination might be considered as promiscuous reaction explained by the
enzyme involved usually acts on a broad range of substrates.2 The enzymatic mechanism of
oxidative defluorination is still elusive and will require further research.

1.3.3 Others
Enzyme/mediator-based defluorination mechanisms have been investigated; here, the
laccase mediated system is introduced as a representative. Laccase is a multi-copper-containing
oxidase capable of oxidizing various small-molecule redox mediators into radical forms. The
highly motile redox mediators could play a role as electron shuttles by approaching the degradation
targets, which might be insoluble or distant from the active site in the laccase.86 A laccase-
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catalyzed oxidative humification reaction system, applying 1-hydroxybenzoriazole as the mediator,
could decompose both PFOA and PFOS, recovering 20% to 30% of total fluorine as inorganic
fluoride.87,

88

Defluorination of PFOA by horseradish peroxidase in the presence of 4-

methoxyphenol as the mediator has also been reported. The C-F bonds in PFOA were nonspecifically attacked by the radical intermediates generated in the enzyme reaction.89
Compared to other defluorination mechanism, reductive defluorination (Figure 1.2) has
rarely been reported and there is no conclusive evidence for enzymatic reductive defluorination
identified so far. The gene expression study in a defluorinating active consortium KB-1
demonstrated that reductive dehalogenases acting on trichloroethylene were not upregulated under
a defluorination condition.80

1.4 Research objectives
Fluorinated chemicals have emerged as recalcitrant pollutants and the strength of C-F
bonds is seen as the major obstacle to developing an efficient bioremediation strategy. Success in
isolating and characterizing a pure culture of microorganism capable of efficiently breaking the CF bond is of great interest. Pseudomonas sp. strain 273 was previously isolated from soil samples
with the capability of utilizing C5 to C12 α,ω-dichloroalkanes as sole carbon substrate resulting in
the release of a stoichiometric amount of chloride. The capability of this organism to defluorinated
different fluorinated organics has not been determined. The research objectives of the present work
are proposed as the following:
1.

Demonstrate defluorination capability of Pseudomonas sp. strain 273 to different

fluorinated organics. (Chapter 2)
2.

Apply a metabolomic approach to speculate degradation and defluorination pathway of

fluoroalkane in strain 273. (Chapter 2)
3.

Apply a metabolomic approach to unravel the anabolic pathway of incorporating the

fluorine into the cell membrane in strain 273. (Chapter 3)
4.

Apply both genomic and transcriptomic approaches to understand the transcriptional

response to fluoroalkane and identify enzyme(s) involved in defluorination in strain 273. (Chapter
4)
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Appendix

Figure 1. 1. Representatives of naturally-occurring and anthropogenic fluorinated organics in the
biosphere and environment.
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Figure 1. 2. Dehalogenation mechanisms reported in microbial activities resulting in release of
halide from halogenated organics.
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Chapter 2. Defluorination of fluoroalkanes by
Pseudomonas sp. strain 273
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The following chapter is modified from a manuscript published in 2020 in the journal
Environmental Science & Technology, volume 54, issue 23, pages 14994 to 15003.
2.1 Abstract
Fluorinated organic compounds, in particular per- and polyfluoroalkyl substances (PFAS),
have emerged as environmental constituents of concern. We demonstrate that the soil isolate
Pseudomonas sp. strain 273 utilizes fluorinated alkanes, including 1-fluoroheptane, 1-fluorooctane,
1-fluorononane, 1-fluorodecane (FD), 1-fluorotetradecane and 1,10-difluorodecane (DFD), as the
sole carbon and energy sources in the presence of oxygen. Strain 273 degraded FD (5.97 ± 0.22
mM) and DFD (5.62 ± 0.13 mM, both nominal concentrations) within 7 days of incubation, and
92.7 ± 3.8% and 90.1 ± 1.9% of the theoretical maximum amounts of fluorine were recovered as
inorganic fluoride, respectively. With n-decane, strain 273 attained (3.24 ± 0.14) × 107 cells per
µmol of carbon consumed, while lower yields of (2.48 ± 0.15) × 107 and (1.62 ± 0.23) × 107 cells
were measured with FD or DFD as electron donors, respectively. The organism coupled decanol
and decanoate oxidation to denitrification, but the utilization of (fluoro)alkanes was strictly
oxygen-dependent, presumably because the initial attack on the terminal carbon requires oxygen.
Fluorohexanoate was detected as an intermediate in cultures growing with FD or DFD indicating
that the initial oxidation reaction can occur on the terminal methyl or fluoromethyl groups of
fluoroalkanes. The findings indicate that specialized bacteria such as Pseudomonas sp. strain 273
can break carbon-fluorine bonds with oxygenolytic enzyme systems, suggesting fluorinated
alkanes are susceptible to microbial degradation.

2.2 Introduction
The widespread use of fluorinated organic chemicals as refrigerants, surfactants, lubricants,
pharmaceuticals, pesticides, aqueous film forming foam (AFFF) mixtures, etc. has resulted in the
release of these compounds into the environment.1-4 Many fluorinated organic chemicals are
recalcitrant, and recent studies demonstrated that a specific group of fluorinated organics, the socalled per- and polyfluoroalkyl substances (PFAS), are globally distributed and may impact
environmental and human health.5-7 Recalcitrance of fluorinated compounds has been explained
by the lack of naturally occurring fluoroorganics and the strength of the carbon-fluorine (C-F)
bond.8 Fluorinated organics have been considered xenobiotics; however, there is clear evidence
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that geologic9-11 and biologic systems12-15 generate C-F bonds. For example, certain plants and
some members of the grampositive Actinomycetales order synthesize monofluoroacetate and fluorinated fatty acids.16 A fluorinase that incorporates fluoride into organic molecules has also
been identified and characterized in Streptomyces cattleya.13 The observation that the C-F bond is
not solely anthropogenic implies that fluorinated organics have long been part of the biosphere,
and microorganisms have had ample time to evolve strategies for breaking C-F bonds.
The strength of the C-F bond has served as an argument against direct enzymatic attack
and microbial degradation of fluorinated compounds;17, 18 however, a number of studies have
demonstrated that naturally occurring microorganisms possess enzyme systems that break C-F
bonds at neutral pH and at room temperature.19-21 Bacteria can catalyze C-F bond cleavage via
oxygenolytic,21 hydrolytic,22 reductive23-25 and hydration26 mechanisms. In one instance, evidence
for organohalide respiration with monofluoroacetate has been obtained,27 suggesting that microbes
can conserve energy by breaking C-F bonds via reductive defluorination.28 Under oxic conditions,
some bacteria and fungi with specific hydrolytic haloacid dehalogenases degrade
monofluoroacetate.29, 30 Pseudomonas sp. strain D2 has been reported to perform defluorination
reactions to access the sulfur in certain fluorinated aliphatic sulfonates under oxic, sulfur-limiting
growth conditions.31 Reductive defluorination of certain PFAS has been demonstrated in vitro
using reduced corrinoids, which are biomolecules.32-36 Further, co-metabolic defluorination linked
to aerobic methanotrophy has been reported.37 Aureobacterium sp. strain RHO25 possesses an
enzyme system that removes the fluorine substituent from 4-fluorobenzoate to form 4hydroxybenzoate.38 This organism was unable to grow with 4-chlorobenzoate, 4-bromobenzoate,
and 4-iodobenzoate, suggesting that the initial enzyme system releasing the para fluorine
substituent specifically evolved to catalyze a defluorination reaction. These observations
demonstrate that microbes can catalyze C-F bond cleavage, thereby refuting the perception that
bond strength prevents biological systems from breaking these bonds.
Terminally and partially fluorinated alkanes have industrial and medical applications.4, 39
Certain plant species, in particular members of the family Dichapetalaceae synthesize monofluorinated fatty acids, and 1-fluorodecane (FD) has been detected in the abdominal glands of
African weaver ants.40, 41 A potentially significant source of partially fluorinated alkanes stems
from the application of AFFF and the transformation of PFAS mediated by aggressive physical-

24

chemical treatments or biological defluorinating systems.42, 43 To date, the environmental fate of
alkanes with a low degree of fluorination is unclear.
The soil isolate Pseudomonas sp. strain 273 has been shown to grow with C5 to C12 ,dichloroalkanes under oxic conditions.44, 45 During growth, stoichiometric amounts of inorganic
chloride were released and preliminary data implicated the involvement of a monooxygenase in
dechlorination.44 Dechlorinating enzyme systems often also cleave C-Br and C-I bonds, but not CF bonds.46 Unexpectedly, we observed growth of strain 273 with C7 to C10 and C14 fluorinated
alkanes as the sole source of carbon and energy under oxic conditions with concomitant fluoride
release, indicating that this organism has the ability to break C-F bonds. Experiments with
Pseudomonas sp. strain 273 demonstrated that fluorinated alkanes are not inert and susceptible to
defluorination and degradation under oxic conditions.

2.3 Materials and Methods
Chemicals.
1-Fluorotetradecane (purity > 97%), 1-flurodecane (FD) (> 97%), 1-fluorononane (> 98%),
1-fluorooctane (> 99%), 1-fluoroheptane (> 99%), and 1-fluorohexane (> 99%) were obtained
from SynQuest Labs, Inc., Alachua, FL, USA. 1,10-Difluorodecane (DFD) (> 97%) was custom
synthesized by Carbosynth, Newbury, UK. Isocetane (> 98%), sodium decanoate, disodium
sebacate, sodium fluoride, sodium acetate, sodium trifluoroacetate (TFA), boron trifluoride,
nitrous oxide (N2O, > 99%) and fatty acid methyl ester (FAME) standards were obtained from
Sigma-Aldrich, St. Louis, MO, USA. n-Decane (decane, > 99%) and 1,10-dichlorodecane (DCD)
(> 98%) were obtained from Acros Organics, Fair Lawn, NJ, USA. n-Hexane (hexane, > 99.8%),
methanol (> 99.9%) and sodium nitrite were obtained from Fisher Chemical, Pittsburgh, PA, USA.
Sodium monofluoroacetate (MFA) was obtained from MP Biomedicals, Solon, OH, USA.
Dinitrogen, helium (both ultra-high purity) and acetylene (> 99.99%) were obtained from Airgas,
Radnor Township, PA, USA. Bradford 1x dye reagent was obtained from Bio-Rad Laboratories,
Hercules, CA, USA. Bovine serum albumin was obtained from Fisher Bioreagents, Pittsburgh, PA,
USA. All other chemicals used were of analytical reagent grade or higher.
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Cultivation of Pseudomonas sp. strain 273.
Strain 273 was isolated from garden soil and taxonomically characterized as a
pseudomonad.44 Strain 273 was grown in completely synthetic, defined mineral salts medium that
comprised (per liter): 6.34 g of Na2HPO4, 1.33 g of KH2PO4, 1.0 g of (NH4)2SO4, 0.2g of
MgSO4·7H2O, the Wolin vitamin mix47 and a trace metal solution.44 To avoid precipitate formation,
a 10-fold concentrated phosphate buffer stock was autoclaved separately and added to the medium
after the solutions had cooled to room temperature. The final medium pH was 7.3. The vitamins
were added from a filter-sterilized (0.2 µm polyethersulfone membrane filter, Thermo, Waltham,
MA, USA) stock solution. The culture was routinely grown in 160-mL serum bottles containing
50 mL of medium and 110 mL of air headspace. The bottles were closed with black butyl rubber
stoppers (Bellco Glass Inc., Vineland, NJ, US) held in place with aluminum crimps (Bellco Glass
Inc., Vineland, NJ, USA). Neat hydrocarbons (e.g., decane) were added to autoclaved medium
with 5-µL glass micro-syringes (Hamilton, Reno, NV, US) to reach initial (nominal) substrate
concentrations ranging from 0.5 to 5 mM, which is higher than the maximum aqueous phase
solubility of the hydrocarbons tested (Appendix, Table S2.1). Due to immiscibility of the mediumchain hydrocarbons with water, the quantification of C10 hydrocarbons required sacrificial
sampling. For time-series quantification, triplicate cultures were grown in 20-mL glass vials
containing 2 mL of medium. The vials were closed with Teflon-lined butyl rubber septa held in
place with aluminum crimps. To ensure that oxygen availability was not limiting alkane
degradation, the vials were pressurized by injecting 18 mL of air (~2 atm). Independent
experiments with larger incubation vessels and a decreased liquid-to-headspace volume ratio (i.e.,
160-mL serum bottles with 10 mL of medium) verified the results obtained with the 20-mL glass
vials. All vessels were shaken at 120 rpm in upright position and incubated at 30C.

Substrate range.
The maximum aqueous phase solubility of the fluorohydrocarbons differed according to
chain length (µM values for 25°C in parentheses): FD (15.7), 1-fluorononane (51.9), 1fluorooctane (172.5), 1-fluoroheptane (573.6), and 1-fluorohexane (1,910.4) (Table S2.1). To test
the range of fluorinated alkanes that strain 273 could utilize as growth substrates, cultures received
fluoroalkanes dissolved in a water immiscible carrier phase (i.e., isocetane). This procedure
avoided potentially toxic effects of shorter fluoroalkanes with higher aqueous phase solubility.
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Stock solutions of fluoroalkanes (14.48-15.97 mg) in isocetane (2 mL) were prepared
gravimetrically and fluoroalkane stock concentrations ranged from 49.3 to 69.5 mM (Table S2.1).
Stock solutions of fluoroalkanes (0.5 mL) were transferred to 20-mL glass vials containing 10 mL
of sterile medium and inoculated (1%, vol/vol). The aqueous phase concentrations of fluoroalkanes
(0.32-40.45 µM) at equilibrium were calculated based on n-octanol/water partition coefficient
(KOW) (Table S2.1). Triplicate cultures were established including control cultures that received
only isocetane. The vials were covered with aluminum foil and shaken at 120 rpm at 30C. Growth
occurred in positive control cultures that received FD dissolved in the carrier phase, indicating that
0.5 mL of isocetane did not prevent FD degradation.
To investigate the range of fatty acids that strain 273 could utilize as carbon sources, stock
solutions (prepared in Milli-Q water) of sodium decanoate, disodium sebacate, MFA or TFA were
autoclaved and added to the medium with sterile 1-mL plastic syringes (Becton, Dickinson and
Company, Franklin Lakes, NJ, USA). In the cases of MFA (1-2 mM) and TFA (2 mM), cometabolism were tested with decane (5 mM, nominal) supplied as primary substrate, and the
headspace were flushed daily with air during the incubation.
To determine whether strain 273 is a complete denitrifier, the organism was grown in
anoxic medium (50 mL) with nitrate (2mM, 100 µmol), nitrite (2 mM, 100 µmol) or N2O (0.42
mM, 100 µmol) as electron acceptor in 160-mL glass serum bottles. Acetate (10 mM, 500 µmol)
was provided as electron donor. Control cultures received acetylene (11 mL, 10% of headspace)
to inhibit N2O reduction.48
To test whether oxygen was required for fluoroalkane degradation, strain 273 was grown
under anoxic conditions with 2 mM nitrite as electron acceptor, and decanoate, decane, and FD (1
mM, nominal) provided as electron donors (four replicate cultures each). To remove oxygen, the
headspace of the 160-mL serum bottles was evacuated (-10 psig for 30 sec) and purged with
oxygen-free nitrogen (three cycles). Four replicate cultures of strain 273 with FD and an air
headspace served as positive controls. Four additional control cultures were maintained under
anoxic conditions with 2 mM nitrite and FD for 7 days before the dinitrogen headspace was
replaced with air. All cultures were inoculated (1%, vol/vol) from a strain 273 culture grown with
decanoate and nitrite under anoxic conditions.

27

Resting cell assays.
Strain 273 was grown with decane (5 mM, nominal) under oxic conditions in two 2-L glass
bottles each containing 1.5 L of medium. The bottles were covered with aluminum foil to allow
gas exchange and shaken at 120 rpm at 30C. The cells were harvested after 6 days (OD600nm
readings of about 0.1) by centrifugation at 11,325  g at 20C for 20 min. The cell pellets were
suspended in 200 mL of sterile mineral salt medium, and 2 mL of cell suspension (0.7 mg protein
mL-1, Figure S2.1) was transferred to three sets of 20-mL glass vials, each set receiving 2 µL of
decane (5.1 mM), FD (4.9 mM), and DFD (4.7 mM, all nominal). The vials were sealed with
Teflon-lined butyl rubber septa held in place with aluminum crimps and pressurized (~ 2 atm) with
air. At each sampling event, triplicate vials from each set were sacrificed for liquid extraction and
quantification of hydrocarbon remaining.

Growth yields.
To compare growth yields with different (halo)carbon substrates, strain 273 cultures
received decane (15.5  0.7 µmol, 1.55  0.07 mM), FD (14.6  0.4 µmol, 1.46  0.04 mM), DFD
(15.3  0.6 µmol, 1.53  0.06 mM), DCD (14.4  0.7 µmol, 1.44  0.07 mM), acetate (69.6  1.8
µmol, 6.96  0.18 mM), sodium decanoate (12.6  0.2 µmol, 1.26  0.02 mM) or disodium
sebacate (12.3  0.4 µmol, 1.23  0.04 mM) in 160-mL serum bottles containing 10 mL of medium
and were closed with black butyl rubber stoppers. Dedicated 5-µL glass microsyringes were used
to add 3 µL of the different hydrocarbons, and gravimetric measurements determined the exact
amounts of hydrocarbons added. The amount of oxygen in the headspace allowed complete
oxidation of the carbon substrates (i.e., electron acceptor present in at least 5-fold excess of the
theoretical demand). After a 7-day incubation period, 2 mL of culture suspension samples were
collected for liquid extraction to quantify hydrocarbons remaining in the medium. Growth yields
were measured with a qPCR assay targeting the 16S rRNA gene of strain 273 and the Bradford
assay to quantify protein. For protein quantification, 5 µL of 12 M sodium hydroxide solution were
added to 1 mL of culture suspension to raise the pH above 12. The suspension was incubated in a
boiling water bath for 15 min before the pH was adjusted to circumneutral by adding small volumes
of concentrated hydrochloric acid. Following centrifugation at 13,800 × g for 5 min, the protein
content of the supernatant was measured using the Bradford protein assay. 49 Protein concentrations
were estimated based on six point standard curves spanning a concentration range between 10 and
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125 µg of bovine serum albumin per mL. Absorbance values of samples and standards were
recorded using a Synergy 2 microplate reader (BioTek, Winooski, VT, USA) and 96-well plates
(TPP Techno Plastic Products AG, Trasadingen, Switzerland). Cell enumeration with qPCR
followed established procedures.50 Briefly, 1 mL of culture suspension was passed through 0.22
μm polyvinylidene difluoride membrane filters (Merck Millipore Ltd., Burlington, MA, USA).
The filters were frozen at -80 C before genomic DNA was extracted using the DNeasy Powerlyzer
PowerSoil kit (Qiagen, Hilden, Germany). qPCR used the Power SYBR Green PCR master mix
(Applied Biosystems, Waltham, MA) and was performed on a 7500 Fast Real-Time PCR system
(Applied Biosystems, Waltham, MA). qPCR standard curves were generated with a serial dilution
of a 166 bp long synthetic oligonucleotide (Integrated DNA Technologies, Coralville, IA, USA)
comprising the primer binding sites. Forward primer (5’-3’) F-GCTAGTCTAACCTTCGGGGG
(Tm = 59°C) and reverse primer R-TCCCCTACGGCTACCTTGTT (Tm = 60°C) were designed
using Primer-BLAST NCBI to amplify a consensus region of the strain 273 five 16S rRNA genes
(GenBank accession numbers:

MT504362, MT504414, MT504545, MT624732, and

MT504546).51 The reported cell numbers reflect the presence of five 16S rRNA gene copies per
genome.

Identification of C10 hydrocarbon metabolites.
Strain 273 cultures were grown with decane, FD or DFD as the sole carbon source (7 mM,
nominal) in closed 160-mL serum bottles containing 50 mL of medium and 110 mL of air
headspace. The headspace was flushed daily with air to ensure oxygen was not limiting
hydrocarbon oxidation. Following a 4-day incubation period (OD600nm > 0.08), 10-mL cell
suspension samples were centrifuged (8000 × g, 15 min, room temperature) and washed once with
sterile medium. To identify potential alkane degradation intermediates, fatty acids were extracted
from cell pellets and derivatized for gas chromatography-high resolution mass spectrometry (GCHRMS) analysis. Cellular fatty acids were extracted and derivatized following an established
protocol.52 Following saponification, fatty acids were derivatized to fatty acid methyl esters
(FAME) in acidic methanol and extracted with hexane for analysis by gas chromatography-high
resolution mass spectrometry (GC-HRMS) using a Trace 1300 gas chromatograph (Thermo
Scientific, Waltham, MA, USA) equipped with a FAMEWAX (30 meter, 0.25 mm inner diameter,
0.25 µm film thickness) column (Restek, Bellefonte, PA, USA), a Triplus RSH autosampler
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(Thermo Scientific, Waltham, MA, USA) and an Exactive™ Plus Orbitrap mass spectrometer
(Thermo Scientific, Waltham, MA, USA).53 External FAME standards ranging from C4 to C23 in
length were analyzed to determine retention times. Standards for fluorinated FAME were not
available, and the retention time for these analytes was estimated based on those of the appropriate
non-fluorinated analog. Analytes were putatively identified based on the following criteria:
retention time match to the external standard (within 0.5 min) if standard available; mass accuracy
within 5 ppm of the expected value; and peaks intensities with 5-fold greater area in samples than
the extraction solvent blank injection. Fatty acids 10 carbons and shorter were identified and/or
annotated as metabolites or degradation products of C10 (halo)alkanes. The relative concentrations
of the FAMEs were estimated using total ion intensities determined from integrating the extracted
ion chromatograms (EICs) based on the monoisotopic masses of the protonated ([M+H]+) ions for
each compound with the MAVEN analysis package.54 EICs and mass spectra were plotted using
XCalibur software, Version 4.0.27.19.

Analytical procedures.
Aliphatic hydrocarbons were quantified by gas chromatography (GC) following extraction
with hexane. Briefly, volumes of 4 mL of hexane were transferred with 5-mL graduated glass
pipettes to 20-mL glass vials containing 2 mL of medium. The vials were closed with Teflon-lined
butyl rubber septa held in place with aluminum crimps, vigorously shaken by hand, and left
undisturbed for 10 min at room temperature to allow phase separation. Aliquots (300 µL) of the
upper hexane layer containing the aliphatic hydrocarbons were transferred to glass autosampler
vials and analyzed with an Agilent 7890A GC-MS system equipped with a 7693A liquid
autosampler, a DB624 column (60 m length, 0.32 mm i.d., 1.8 μm film thickness) and a 5975C
mass-selective detector (Agilent, Santa Clara, CA, USA). Helium was used as carrier gas at a flow
rate of 0.6 mL min-1. After injection of 5 µL of the sample at a 50:1 injector split ratio, the oven
temperature increased from 70C to 205C at a rate of 15C min-1, then increased to 230C at a
rate of 25C min-1, and held at this temperature for 1 min. Full scans were acquired between 50 to
500 m/z and monitored at the rate of 2.91 scans/second. The total ion current at the retention time
was confirmed with authentic standards and used for quantification of each compound of interest.
Five-point standard curves prepared with FD and DFD dissolved in hexane spanned a nominal
concentration range of 0.5 to 10 mM FD and DFD. The lower aqueous layer following hexane
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extraction contained the inorganic fluoride, and samples were withdrawn with 1-mL sterile plastic
syringes from carefully inverted vials. Following filtration through 0.2 µm polyethersulfone
syringe filters, fluoride was quantified with an ICS-2100 (Dionex, Sunnyvale, CA, US) ion
chromatography system equipped with a 4 mm  250 mm IonPac AS18 hydroxide-selective anionexchange column and a conductivity detector. The method detection limit for fluoride was 13.4
µM. MFA and acetate were measured with an Agilent 1200 series HPLC system (Agilent, Santa
Clara, CA, USA) equipped with an Aminex HPX-87H ion exclusion column (Bio-Rad Lab.,
Hercules, CA, USA) and a G1365D multiwavelength detector (Agilent, Santa Clara, CA, USA).
Decanoate and sebacate were both esterified using boron trifluoride (BF3) as a catalyst.
Briefly, aqueous samples were 100-fold diluted with Milli-Q water to enhance derivatization
efficiency. Samples (250 µL) were mixed with 500 µL 14% (w/w) BF3 in methanol in glass screw
top vials and incubated in a water bath at 60°C for 1 hour. After cooling to room temperature, the
vials were vortexed followed by the addition of 1 mL of Milli-Q water and 1 mL of hexane and
left undisturbed for 10 minutes at room temperature to allow phase separation. From the top hexane
layer, 500 µL was transferred to a GC autosampler vial for analysis. Methyl esters of decanoate,
sebacate and extracted whole cell fatty acids were all analyzed by GC-HRMS. The GC was
coupled to an Exactive™ Plus Orbitrap mass spectrometer (Thermo Scientific, Waltham, MA,
USA) using an atmospheric pressure chemical ionization interface. Samples were injected in a 5:1
split ratio using a programmable temperature vaporizer inlet operated at 240°C and using ultra
high purity helium as a carrier gas at a flow rate of 1.7 mL min -1. The initial column temperature
was 80°C held for 5 minutes and increased to 240°C at a rate of 10°C min-1. The mass spectrometer
was operated in positive mode at a resolution of 140,000 scanning from 70 to 500 m/z with an
automated gain control target of 3e6 and 50 ms maximum inject time. To determine concentrations
of sebacate and decanoate, the most responsive ion of derivatized product (i.e., methyl decanoate
and dimethyl sebacate) was selected for standard curve establishment and concentration
determination. Oxygen and N2O in culture headspace samples were quantified with an Agilent
7890A GC system equipped with an HP-PLOT/Q column (30 m length, 0.32 mm i.d., 20.0 µm
film thickness) and a micro-electron capture detector. Optical density (OD 600 nm) readings were
obtained after gently vortexing 1 mL of culture suspension using a 20D+ spectrophotometer
(Thermo Scientific, Waltham, MA, USA).
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Statistical analysis.
Significant differences between growth yields with different hydrocarbons were examined
by Duncan’s multiple range test using SPSS Statistics (Version 26, SPSS Inc., Chicago, IL). The
calculation of the Pearson correlation coefficient between cell number and protein concentration
measurements and the linear regression of OD600nm and protein concentration measurements were
both performed using SPSS Statistics (Version 26).

2.4 Results
Growth of Pseudomonas sp. strain 273 with fatty acids, alkanes and fluoroalkanes.
Pseudomonas sp. strain 273 grew with 1-fluorodecane (FD) as the sole source of carbon
with concomitant release of inorganic fluoride in the presence of oxygen (Figure 2.2). Cultures
completely consumed 5.97 ± 0.22 mM (11.94 ± 0.44 µmol) FD within 1 week and produced 5.53
± 0.23 mM (11.06 ± 0.46 µmol) fluoride, which accounted for 92.7 ± 3.8% of the total fluorine
contained in the substrate (Figure 2.2 A). Growth and defluorination were also observed in cultures
amended with 1-fluorotetradecane, 1-fluorononane, 1-fluorooctane and 1-fluoroheptane (Table
2.1). No growth occurred in cultures that received 0.5 mM 1-fluorohexane. In case this was due to
toxicity from the higher aqueous concentrations of the shorter fluoroalkanes, an isocetane carrier
phase was used to lower the aqueous phase concentrations to ~40 µM for 1-fluorohexane. No
growth was observed under these conditions or with isocetane alone. Strain 273 grew with the
,-fluorinated alkane 1,10-difluorodecane (DFD), and cultures completely consumed 5.62 ± 0.13
mM (11.24 ± 0.26 µmol) DFD within 1 week with concomitant release of 10.14 ± 0.22 mM (20.28
± 0.44 µmol) fluoride, which accounted for 90.1  1.9% of the total fluorine contained in the initial
amount of DFD (Figure 2.2 B). Neither defluorination nor growth occurred in autoclaved control
cultures or in vessels without inoculum.
Growth also occurred with 1,10-dichlorodecane (DCD), decane, decanol, decanoate,
sebacate, and acetate as the sole carbon and energy sources in the presence of oxygen (Table 2.1).
No growth was observed in cultures amended with monofluoroacetate (MFA) or trifluoroacetate
(TFA) as the sole carbon source; however, partial MFA degradation occurred in cultures that
received decane as the primary substrate in the presence of oxygen. Over the course of a 17-day
incubation period, 0.15  0.03 mM MFA (7.35  1.30 µmol or 12.4  2.7% of the initial amount),
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was consumed with the concomitant release of 0.15  0.03 mM (7.26  1.59 µmol) fluoride (Figure
2.3). Co-metabolic degradation of TFA was not observed.
Strain 273 cultures that received decanoate, sebacate or acetate (i.e., fatty acids) as a carbon
substrate produced (10.55 ± 0.82) × 107, (9.71 ± 1.15) × 107 and (5.22 ± 1.34) × 107 cells per µmol
of carbon consumed, respectively (Table 2.2). Among all the alkane substrates, the highest growth
yield of (3.24 ± 0.14) × 107 cells per µmol of carbon consumed was observed in cultures grown
with decane. A slightly lower growth yield of (2.48 ± 0.15) × 107 cells per µmol of carbon
consumed was observed with FD. Cultures grown with DFD or DCD produced significantly fewer
cells and (1.62 ± 0.23) × 107 and (1.61 ± 0.61) × 107 cells per µmol of carbon consumed were
determined, respectively. Protein quantification was used as an independent measure of growth
and corroborated the growth yields determined with qPCR (Table 2.2). Strain 273 produced 5.35
± 0.32, 5.03 ± 0.21 and 2.53 ± 0.14 µg of protein per µmol of carbon consumed in cultures that
were fed decanoate, sebacate or acetate, respectively. With decane, FD, DCD or DFD as a carbon
substrate, 2.04 ± 0.31, 1.89 ± 0.43, 1.51 ± 0.75 and 1.24 ± 0.58 µg of protein per µmol of carbon
consumed were measured, respectively (Table 2.2). Cell and protein yield measurements showed
a significant correlation (Pearson correlation coefficient, r = 0.95, p < 0.01) (Figure 2.4),
supporting the observation of lower growth yields with halogenated alkanes.

Resting cell experiments.
Dense cell suspensions of strain 273 obtained with decane as a carbon source consumed
decane, FD and DFD without an apparent lag phase (Figure 2.5). DFD was consumed at the highest
rate of 0.89 ± 0.09 µmol h–1 mg–1 protein, and 10.30 ± 0.14 µmol of DFD was completely
consumed over a 12-hour incubation period (Figure 2.5). FD and decane were consumed at lower
rates of 0.55 ± 0.08 µmol h–1 mg–1 protein and 0.63 ± 0.05 µmol h–1 mg–1 protein, respectively.

Denitrification test on strain 273.
Growth in the absence of oxygen was investigated in anoxic medium with nitrite or N2O
as electron acceptor and excess acetate as electron donor (Table 2.3). Complete consumption of
104.2 ± 4.5 µmol (2.08  0.09 mM) of nitrite was coupled with the oxidation of 42.7 ± 1.1 µmol
(0.85  0.02 mM) of acetate. No N2O was detected in the cultures at the end of the 7-day incubation
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period. In cultures that received 100.0 ± 11.6 µmol (0.42 ± 0.05 mM) of N2O as electron acceptor,
N2O was completely reduced and 27.8 ± 4.4 µmol (0.56 ± 0.09 mM) of acetate were consumed
over a 7-day incubation period, indicating that strain 273 possesses a functional nos operon
responsible for the reduction of N2O to N2. In cultures that received 112.0 ± 9.2 µmol (2.24 ± 0.18
mM) of nitrite as electron acceptor and the N2O reductase inhibitor acetylene, 60.0 ± 6.2 µmol
(0.25 ± 0.03 mM) of N2O were measured after a 7-day incubation period, indicating stoichiometric
conversion of nitrite to N2O. Electron recoveries calculated for cultures that received nitrite or N2O
as electron acceptors corroborated the involvement of the canonical denitrification pathway (Table
2.3). In cultures amended with nitrite, nitrite plus acetylene, or N2O, 91.5 ± 4.0%, 84.8 ± 7.0% and
89.9 ± 10.4% of the electrons released from acetate oxidation were accounted for in the amount of
the electron acceptor consumed, respectively.

Oxygen requirement for (halo)alkane degradation.
In addition to acetate, strain 273 utilized decanol and decanoate as electron donors for
nitrite reduction (Table 2.1). With decanoate (1 mM, 50 µmol) as electron donor, 1.79 ± 0.04 mM
nitrite (89.5 ± 2.0 µmol) was consumed over a 7-day incubation period (Figure 2.6 A). In anoxic
cultures amended with nitrite as electron acceptor and decane as electron donor, neither growth
nor nitrite consumption nor decane degradation occurred (Figure 2.6 B). Similar observations were
made with FD as electron donor, and no inorganic fluoride was released in anoxic incubations with
nitrite as electron acceptor (Figure 2.6 C). Conversely, both growth and fluoride release occurred
in positive control vessels that received FD with oxygen as electron acceptor (Figure 2.6 D). In
anoxic cultures amended with nitrite, the consumption of FD and the release of inorganic fluoride
emerged after the nitrogen headspace had been replaced with air (Figure 2.6 E).

Detection of (halo)alkane metabolites.
Microbes metabolize alkanes via oxidation, majorly beta-oxidation to shorter chain.55
Based on the matching selection criteria, the GC-HRMS analysis identified a total of ten classes
of saturated fatty acids as potential metabolites during growth of strain 273 with decane, FD, or
DFD (Table S2.2). Even-chain fluorinated fatty acids, including fluorodecanoate, fluorooctanoate,
and fluorohexanoate, were detected in cultures grown with DFD. Methyl fluorohexanoate was
detected in both FD- (intensity of 3.7 × 105) and DFD- (intensity of 9.7 × 105) grown cultures
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(Figure 2.7 A). The spectra determined for methyl hexanoate and methyl fluorohexanoate in the
respective retention times revealed mass accuracy tolerances of 3 ppm, which supported formula
identification (Figure 2.7 B). Mono-substitution of hydrogen to fluorine lowering the vapor
pressure and increasing the boiling point of short chain hydrocarbons has been previously
demonstrated.56, 57 This phenomenon would explain the later retention times of the peaks annotated
as mono-fluorine substituted FAMEs by GC.

2.5 Discussion
Only a few organisms have been described that degrade halogenated alkanes, and the
substrate range for most of the characterized halogenated alkane degraders has been restricted to
chlorinated, brominated, and iodinated alkanes.58-60 In contrast, Pseudomonas sp. strain 273, the
focus of the current study, utilizes C7 to C10 and C14 monofluoroalkanes and DFD as growth
substrates with concomitant release of inorganic fluoride. Apparently, this organism possesses one
or more enzyme systems that lead to C-F bond breakage in alkanes with fluorine substitution in
one or both terminal methyl groups.

Oxidation of the terminal carbon and degradation pathway of (halo)alkanes in strain 273.
The growth studies demonstrated that alkane degradation only occurred in the presence of
oxygen. Presumably, oxygen is a required co-substrate for the initial attack in the terminal carbon
atom and conversion to the respective alcohols via a monooxygenase catalyzed reaction.61 Prior
work implicated the same monooxygenase enzyme system of strain 273 in the initial attack on
decane and on 1,10-dichlorodecane (DCD).44 The lack of an apparent lag phase when dense cell
suspensions of decane-grown cells were challenged with FD or DFD (Figure 2.5) suggests that no
de novo enzyme biosynthesis was required to initiate FD and DFD degradation. Therefore, it is
likely that the same monooxygenase enzyme system is responsible for the initial reaction with
decane, FD, and DFD. An alternate explanation would be the constitutive expression of a
monooxygenase that causes C-F bond cleavage; detailed expression studies under various growth
conditions would be needed to reveal whether a single or multiple monooxygenase enzyme
systems are involved in (halo)alkane degradation.
In light of the experimental observations, a single pathway is likely utilized for the
degradation of (halo)alkane degradation in strain 273 (Figure 2.8). The detection of even-chain
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fluorinated fatty acids (fluorohexanoate, fluorooctanoate and fluorodecanoate) suggests that the
initial oxidation can occur at either a terminal methyl or fluoromethyl carbon, given the ability to
degrade decane, FD and DFD. In the case of decane, the initial oxidation product would be the
corresponding alcohol (i.e., decanol), which would then be oxidized to a carboxylic acid that could
be used for -oxidation or anabolic pathways. Analogously, the initial attack of a monooxygenase
on the terminal fluoromethyl group carbon would generate a geminal fluorohydrin that could then
spontaneously eliminate fluoride to form the corresponding aldehyde, which could be further
oxidized to a carboxylic acid.19,62 No monooxygenase enzyme system has been characterized in
strain 273; therefore it is unknown whether the enzyme(s) has (have) a preference for the terminal
methyl group carbon or the fluoromethyl group carbon. For both FD and DFD, -oxidation could
lead to the formation of fluoroacetyl-CoA, which is potentially toxic (Figure 2.8). Utilization of
fluoroacetyl-CoA by the tricarboxylic acid cycle (TCA) cycle would result in the formation of
fluorocitrate, a known inhibitor of aconitase, a key TCA cycle enzyme.63-65 Although
monofluoroacetate (MFA) did not support growth of strain 273, co-metabolism of MFA and
fluoride release were observed when decane was the primary substrate. These observations suggest
that strain 273 has mechanisms to defluorinate MFA and monofluoroacetyl-CoA.
Theoretically, both terminal carbon atoms of the alkane could be attacked by the
monooxygenase,19 , 66 which would transform FD and DFD to the corresponding dicarboxylates.
Such a mechanism would avoid the formation of fluoroacetyl-CoA. A purified monooxygenase of
the alkane hydrocarbon degrader Pseudomonas oleovorans could not only hydroxylate n-alkanes
to the corresponding primary alcohols but could also convert fatty acids to their -hydroxy
derivates,67,68 suggesting that attacks on both ends of the alkane molecule by the same
monoxoygenase enzyme system could occur. However, the detection of fluorinated fatty acid
metabolites in strain 273 cultures does not support the formation of dicarboxylic acids (Figure 2.8).

Metabolic burden of (fluoro)alkane degradation.
Strain 273 attained approximately 3-fold more biomass per µmol of carbon utilized with
decanoate or sebacate compared to decane as carbon substrate (Table 2.2). Even lower growth
yields were measured in cultures grown with halogenated alkanes, declining about 50% with DFD
and DCD compared to the yield with decane (Table 2.2). The standard Gibbs free energy changes
associated with complete oxidation of decane, halogenated C10 alkanes, decanoate and sebacate
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are in a similar range (Table S2.3); thus, thermodynamics alone cannot explain the measured
growth yield differences. Possible explanations for the lower growth yields with decane and
(halo)alkanes compared to the corresponding fatty acids may include the required synthesis of the
monooxygenase enzyme system(s) and/or the production of biosurfactant(s) needed for
emulsifying the sparingly soluble (halo)alkanes. Strain 273 might produce the biosurfactant(s) to
efficiently solubilizes water-insoluble alkanes.44 The production of biosurfactants by prolific oil
hydrocarbon-degrading bacteria is a well-studied phenomenon, and several Pseudomonas spp.
were shown to produce rhamnolipids to emulsify hydrocarbons with a low solubility in water.69-71
Conversely, growth with water-soluble decanoate and sebacate does not burden the cells with the
synthesis of the monooxygenase enzyme system and biosurfactant(s). This reasoning cannot
explain the lower growth yields with FD and DFD compared to cultures that were grown with
decane. The GC-HRMS analysis detected -fluorofatty acids as intermediates during growth with
both FD and DFD. -Fluorofatty acids are precursors of potentially inhibitory fluoroacetyl-CoA.
For FD, preferential initial oxidation of the fluoromethyl carbon would avoid the formation of fluorinated intermediates and fluoroacetyl-CoA. In this case, cultures fed with FD or decane should
exhibit similar growth yields; however, the experimental data determined about 23.4 ± 4.7% lower
growth yields with FD. This observation suggests that the monoxygenase may not discriminate
between the  and the  positions of FD and oxidizes both the methyl and the fluoromethyl group
carbon atoms. In the case of DFD, the initial attack must occur on one of the two fluoromethyl
groups, and the formation of fluorinated metabolites (e.g., -fluorofatty acids, fluoroacetyl-CoA)
could explain the observed reduction in growth yields with DFD (Table 2.2). Fluoride toxicity
offers another potential explanation for the lower growth yields with FD and DFD, which would
only occur during growth with fluorinated electron donors.72

Implications for the fate of fluorinated compounds.
Knowledge about the presence and the distribution of organofluorines in environmental
systems is rapidly evolving, and improved understandings of the processes that affect the fate and
longevity of fluorinated compounds is needed. Physical,73 chemical,74 and biological75,
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approaches, as well as combined treatments77 have been shown to transform PFAS and to generate
partially defluorinated alkyl products. The data herein demonstrate that α,-fluorinated alkanes
are susceptible to microbial degradation and that organisms with defluorinating oxygenase enzyme
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systems may contribute to the degradation of AFFF components and partially defluorinated PFAS
transformation products (i.e., compounds with non-perfluorinated carbon atoms) generated during
aggressive remedial treatment. Therefore, future efforts should explore whether organisms like
Pseudomonas sp. strain 273 have value in sequential treatment (i.e., combined remedy) approaches
and might achieve more complete fluoride release.
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Appendix

Figure 2. 1. Graphical abstract of research contents in chapter 2.
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A

B

Figure 2. 2. Degradation of (A) 1-fluorodecane (FD) and (B) 1,10-difluorodecane (DFD) by strain
273 and the concomitant release of fluoride. The data represent the averages of triplicate
incubations and error bars represent the standard deviations.
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Figure 2. 3. Consumption of monofluoroacetate (MFA) and release of fluoride in strain 273
cultures amended with decane as a primary substrate. The data represent the averages of two
replicate cultures and the error bars represent the standard deviations.
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Figure 2. 4. Pearson correlation between cells produced and protein yields per µmol of carbon
consumed with different carbon substrates. The data were collected from cultures grown with
acetate,

decanoate,

sebacate,

decane,

1-fluorodecane,

1,10-difluorodecane

and

1,10-

dichlorodecane. A linear relationship (Pearson correlation coefficient, r = 0.95) was determined at
the 0.01 significance level.
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Figure 2. 5. Consumption of decane, FD and DFD in resting cell suspension assays using strain
273 cells grown with decane. The data represent the averages of triplicate incubations and the error
bars represent the standard deviations.
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Figure 2. 6. Utilization of C10 (fluoro)alkanes and carboxylates by strain 273 under oxic (light
red background) and anoxic (light grey background) conditions. Cultures were supplied with
different electron donor/acceptor combinations including (A) nitrite (2 mM), decanoate (1 mM),
nitrogen headspace; (B) nitrite (2 mM), decane (1 mM), nitrogen headspace; (C) nitrite (2 mM),
FD (1 mM), nitrogen headspace; (D) FD (1 mM), air headspace; (E) FD (1 mM), nitrite (2 mM),
nitrogen headspace, which was replaced with air after 7 days. The data represent the averages of
four replicates and the error bars represent the standard deviations.
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Figure 2. 7. Detection of fluorohexanoate as an intermediate of FD and DFD metabolism by strain
273. (A) Merged extracted ion chromatograms of methyl hexanoate ([M+H]+ = 131.1067 m/z) and
methyl fluorohexanoate ([M+H]+ = 149.0972 m/z) in cultures of strain 273 grown with decane,
FD or DFD. (B) GC-HRMS identification of methyl hexanoate and methyl fluorohexanoate with
a mass accuracy tolerance in 3 ppm to the monoisotopic mass of the putative structure illustrated.
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Figure S2. 1. Linear regression of OD600nm readings versus protein concentration measurements.
The data were collected from strain 273 cultures grown with acetate, decanoate, sebacate, n-decane,
1-fluorodecane, 1,10-difluorodecane and 1,10-dichlorodecane following complete substrate
consumption. Protein concentrations were estimated based on OD 600nm readings according to:
Protein (µg/mL) = 321.54 × OD600nm
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Table 2. 1. Growth and defluorination observed in cultures of Pseudomonas sp. strain 273 with
different electron donor/electron acceptor combinations.
Electron Donor (mM)

Electron Acceptor (mM)

Decane (1c, 5c)
Decane (1c)
1-Fluorodecane (0.5c,1c, 5c, carrierd)
1-Fluorodecane (0.5c, 1c)
1-Fluorodecane (0.5c)
1,10-Difluorodecane (1c, 5c)
1-Fluorotetradecane (1c)
1-Fluorononane (0.5c, carrierd)
1-Fluorooctane (0.5c, carrierd)
1-Fluoroheptane (0.5, carrierd)
1-Fluorohexane (0.5, carrierd)
1,10-Dichlorodecane (1c)
Acetate (2, 5, 10)
Acetate (5, 10)
Acetate (5, 10)
Acetate (5, 10)
Monofluoroacetate (1, 2)
Trifluoroacetate (2)
Monofluoroacetate (1) + decane (5c)
Trifluoroacetate (2) + decane (5 c)
Decanol (1c)
Decanol (1c)
Decanoate (1)
Decanoate (1)
Decanoate (1)
Sebacate (1)

Oxygen
Nitrite (2)
Oxygen
Nitrite (2)
Nitrous oxide (0.42)
Oxygen
Oxygen
Oxygen
Oxygen
Oxygen
Oxygen
Oxygen
Oxygen
Nitrite (1, 2)
Nitrate (2)
Nitrous Oxide (0.42)
Oxygen
Oxygen
Oxygen
Oxygen
Oxygen
Nitrite (2)
Oxygen
Nitrite (2)
Nitrate (2)
Oxygen

Growtha

Defluorinationb

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

NA
NA
+
+
+
+
+
+
NA
NA
NA
NA
NA
+
NA
NA
NA
NA
NA
NA

a

Growth was determined by the increase of culture turbidity and the degradation of substrates.

bDefluorination
cNominal
dIn

was determined by the detection of released fluoride in medium.

concentration.

the presence of an isocetane carrier phase.

NA: Not applicable
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Table 2. 2. Pseudomonas sp. strain 273 growth yields with different carbon substrates.
Carbon
substrate
(electron
donor)

Substrate
consumed
(mM) a

Substrate consumed
(µmol carbon)

Acetate
Decanoate
Sebacate
Decane
FD
DFD
DCD

6.96 ± 0.18
1.26 ± 0.02
1.23 ± 0.04
1.55 ± 0.07
1.46 ± 0.04
1.53 ± 0.06
1.44 ± 0.07

139.18 ± 3.54
125.86 ± 1.64
123.37 ± 4.49
154.60 ± 7.03
145.56 ± 3.60
153.30 ± 6.48
143.62 ± 7.23

Growth yield b
Cell numbers (×
107/µmol carbon)

Protein (µg/µmol
carbon)

5.22 ± 1.34 B
10.55 ± 0.82 A
9.71 ± 1.15 A
3.24 ± 0.14 C
2.48 ± 0.15 C,D
1.62 ± 0.23 D
1.61 ± 0.61 D

2.53 ± 0.14 B
5.35 ± 0.32 A
5.03 ± 0.21 A
2.04 ± 0.31 B,C
1.89 ± 0.43 B,C,D
1.24 ± 0.58 D
1.51 ± 0.75 C,D

a The

carbon substrates were completely consumed after a 1-week incubation period.

b Cell

numbers were determined with qPCR and protein amounts were estimated after alkaline cell

lysis with the Bradford assay. The yield data represent the net increase of cells and protein per
µmol of carbon consumed. For both datasets, the Duncan test ( = 0.05) observed significant
differences between A, B, C and D.
The data represent the averages and the standard deviations of triplicate cultures.
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Table 2. 3. Stoichiometry of electron donor and electron acceptor consumption over a 7-day
incubation period and electron recovery in strain 273 cultures grown with nitrite or nitrous oxide
as electron acceptors.a
Electron acceptor
+ electron donor
Nitrite + Acetate
Nitrite + Acetate f
Nitrous oxide +
Acetate
a

Electron donor
(µmol/bottle)
Added Consumed
477.0 ±
42.7 ± 1.1
3.9
483.0 ±
33.0 ± 4.6
5.4
482.6 ±
27.8 ± 4.4
6.8

Available
electrons b
(µmol/bottle)
341.6 ± 8.8 b
264.0 ± 36.8 b
222.4 ± 35.2 b

Electron acceptor
(µmol/bottle)
Added Consumed
104.2 ±
104.2 ±
4.5
4.5
112.0 ±
112.0 ±
9.2
9.2
100.0 ±
100.0 ±
11.7
11.6

Required
electrons c
(µmol/bottle)

Electron
recovery
(%) d

312.6 ± 13.5 e

91.5

224.0 ± 18.4 g

84.8

200.0 ± 23.2 h

89.9

The data represent averages and standard deviations of triplicates.

b Assuming

the oxidation of 1 mol of acetate generates 8 mol of electrons according to:

CH3COO- + 4 H2O → 2 HCO3- + 8e- + 9H+
c

Electrons required for electron acceptor reduction were calculated according to the following

reduction half reactions:
1

e

NO2- + 3e- + 4H+ → 2N2 + 2H2O

g

NO2- + 2e- + 3H+ → N2O + H2O
2e-

3

2

2

→ N2 + H2O

h

N 2O +

d

Electron recovery (%) = Available electrons  100%

f

Acetylene (10% v:v) was added to the headspace to prevent nitrous oxide reduction.

+

2H+

1

Required electrons
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Table S2. 1. Solubility and n-octanol/water partition coefficient data for carbon substrates tested.

Carbon substrate

1-Fluorohexane
1-Fluoroheptane
1-Fluorooctane
1-Fluorononane
1-Fluorodecane
1,10-Difuorodecane
1,10-Dichlorodecane
Decane
1-Decanol
Sodium Decanoate
Disodium Sebacate
Sodium Acetate

Formula

Molecular
weight
(g/mol)

Water
Solubility
at 25°C
(mg/L) a

Water
Solubility
at 25°C
(mM)

C6H13F
C7H15F
C8H17F
C9H19F
C10H21F
C10H20F2
C10H20Cl2
C10H22
C10H22O
C10H19NaO2
C10H16Na2O4
C2H3NaO2

104.2
118.2
132.2
146.3
160.3
178.3
211.2
142.3
158.3
194.3
246.2
82.0

199
67.8
22.8
7.6
2.51
--0.052
37
>100,000 g
>1,000 h
1,233,000

1.91
0.57
0.17
0.052
0.016
--0.00037
0.23373
>514.7
>4.1
15,037

n-Octanol/
water
partition
coefficient
Kow a
1,698
5,248
16,218
50,119
154,882
--102,329
37,154
----

Log
Kow a
3.23
3.72
4.21
4.7
5.19
--5.01
4.57
----

Carbon
substrate
concentration
in carrier
phase (mM) b
69.5
66.6
58.6
54.6
49.3
--------

Carbon
substrate
per vial
(µmol) c
34.8
33.3
29.3
27.3
24.7
--------

Aqueous
concentration
after
equilibrium
(µM) d
40.45
12.65
3.61
1.09
0.32
--------

Fluoride
released after
2-week
incubation
(µmol)
ND
ND e
17.9 ± 1.1
22.4 ± 1.1
22.4 ± 0.2
NA f
-------

a

Solubility and Kow data were collected from ChemIDPlus database (https://chem.nlm.nih.gov/chemidplus/), unless indicated otherwise.

b

Isocetane served as inert carrier phase to reduce aqueous phase concentration to avoid toxicity. Carbon substrates were dissolved in isocetane in a ratio of 1:100

(v/v) and the exact concentrations were determined gravimetrically.
c

Carbon substrate per vial (µmol) = Carbon substrate concentration in isocetane (mM) × 0.5 mL (total volume of carrier phase added to vial)

d

When carrier phase (i.e. isocetane) was added, the carbon substrate concentration after equilibrium was calculated as follows: Aqueous concentration (µM) =

Total carbon substrate amount per vial (µmol)/ (10+0.5Kow) (mL) × 1000
e

Fluoride release from 1-fluoroheptane was observed when neat 1-fluoroheptane was supplied but not when carrier phase applied.

f

Growth study of 1,10-difluorodecane as the carbon substrate was not tested with carrier phase applied.

g

Data obtained from: https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Product_Information_Sheet/c4151pis.pdf

h

Data obtained from: https://www.parchem.com/siteimages/Attachment/GHS%20Disodium%20Sebacate%20MSDS.pdf

ND: Not detected
NA: Not applied
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Table S2. 2. FAME metabolites detected in cultures of Pseudomonas sp. strain 273 grown with decane, FD and DFD.

Compound

Methyl butyrate
Methyl pentanoate
Methyl hexanoate
Methyl fluorohexanoate
Methyl heptanoate
Methyl octanoate
Methyl fluorooctanoate
Methyl nonanoate
Methyl decanoate
Methyl fluorodecanoate

Formula

C5H10O2
C6H12O2
C7H14O2
C7H13O2F
C8H16O2
C9H18O2
C9H17O2F
C10H20O2
C11H22O2
C11H21O2F

Ionized
form
[M+H]+
[M+H]+
[M+H]+
[M+H]+
[M+H]+
[M+H]+
[M+H]+
[M+H]+
[M+H]+
[M+H]+

Ionized [M+H]+
m/z

[M+H] m/z

Error
(ppm)

103.0754
117.0910
131.1067
149.0972
145.1223
159.1380
177.1285
173.1536
187.1693
205.1598

103.0755
117.0910
131.1064
149.0970
145.1220
159.1375
177.1283
173.1531
187.1688
205.1594

0.97
0.00
-2.29
-1.34
-2.07
-3.14
-1.13
-2.89
-2.67
-1.95

Detected
+

Standard
retention
time

∆RT to
standard

(min)a

Detected
retention
time
(min)

1.46
NA
2.14
NA
NA
4.29
NA
NA
8.16
NA

1.47
1.52
2.16
5.40
2.93
4.33
8.99
6.40
8.19
11.66

0.01
NA
0.02
NA
NA
0.04
NA
NA
0.03
NA

(min)b

Peak intensity

Peak intensity

c

in Decane

0.0E+00
7.0E+05
4.6E+05
0.0E+00
1.7E+05
2.5E+05
0.0E+00
2.5E+05
2.4E+05
0.0E+00

a

The retention times of standard compounds were recorded; NA indicates that the standard was not available.

b

∆RT represents the retention time difference to the standard; NA indicates that the standard was not available.

c,d,e

d

in FD

5.7E+05
1.3E+06
1.4E+06
3.7E+05
1.5E+05
5.2E+05
0.0E+00
3.9E+05
5.2E+05
0.0E+00

Peak intensity
in DFDe
0.0E+00
9.7E+05
1.5E+06
9.7E+05
3.3E+05
5.3E+05
2.7E+03
4.1E+05
1.6E+05
1.7E+05

The blue bars represent the integrated peak area (peak intensity) of the extracted ion chromatogram of each protonated species

([M+H]+) in strain 273 cultures grown with decane, FD or DFD.
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Table S2. 3. Gibbs free energy changes associated with complete oxidation of different carbon substrates including n-decane, 1fluorodecane (FD), 1,10-difluorodecane (DFD), 1,10-dichlorodecane (DCD), acetate, decanoate and sebacate under standard condition.
∆Gf°
∆G° (kJ/mol)
∆G° (kJ/mol) per
Redox reaction a
(kJ/mol)
per mol
mol of carbon
b
+
1-Fluorodecane
-161.5
C10H21F + 15O2 → 10CO2 + 10H2O + F + H
-6,792.2
-679.2
1,10-Difluorodecane
-356.3 b
C10H20F2 + 29/2O2 → 10CO2 + 9H2O + 2F- + 2H+
-6,603.1
-660.3
b
+
1,10-Dichlorodecane
9.46
C10H20Cl2 + 29/2O2 → 10CO2 + 9H2O + 2Cl + 2H
-6,673.7
-667.4
b
Decane
33.3
C10H22 + 31/2O2 → 10CO2 + 11H2O
-6,981.4
-698.1
b
+
Sodium Decanoate
-148.2
C9H19COO + 14O2 + H → 10CO2 + 10H2O
-6,526.7
-652.7
Disodium Sebacate
-329.8 b
C10H16O42- + 25/2O2 + 2H+ → 10CO2 + 9H2O
-6,072.0
-607.2
a
+
Sodium Acetate
-369.3
CH3COO + 2O2 + H → 2CO2 + 2H2O
-965.7
-482.8
a The standard-state free energies of formation (∆G °) of reactants and products used for the calculations are shown below.1
f
Carbon substrate

b

The standard-state free energies of formation (∆Gf°) were calculated by the group contribution method as described. 2
O2
CO2
H2O
FClH+
CH3COO-

∆Gf° (kJ/mol)
0
-394.4
-273.1
-278.8
-131.2
0
-369.3

References for Table S2.3:
1. Widdel, F.; Musat, F., Energetic and other quantitative aspects of microbial hydrocarbon utilization. In Handbook of Hydrocarbon
and Lipid Microbiology, Timmis, K. N., Ed. Springer: Berlin, Heidelberg, 2010; pp 729-763.
2. Joback, K. G.; Reid, R. C., Estimation of pure-component properties from group-contributions. Chem. Eng. Commun. 1987, 57, (16), 233-243.
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Chapter 3. Covalent incorporation of fluorine into the cellular membrane
during growth of Pseudomonas sp. strain 273 with fluorinated alkanes
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3.1 Abstract
Anthropogenic fluorinated organics are recalcitrant, globally distributed, and a human
health concern. Aerobic growth of Pseudomonas sp. strain 273 with 1-fluorodecane (FD) and 1,10difluorodecane (DFD) is associated with the release of inorganic fluoride. A careful mass balance
approach revealed that 7.8  2.2% and 5.5  2.8% of the theoretical amount of fluorine in FD and
DFD, respectively, could not be accounted for as inorganic fluoride. Fatty acid profiling detected
long-chain fluorinated fatty acids in strain 273 cells grown with FD or DFD, but not in cells grown
with non-fluorinated carbon sources. Lipidomics profiling determined that 8.5 ± 0.3% and 90.6 ±
1.3% of the total glycerophospholipids (GP) in strain 273 cells grown with FD or DFD,
respectively, were fluorinated. No evidence was obtained for the incorporation of inorganic
fluoride into biomass. Mass spectrometry analyses revealed the covalent incorporation of a single
fluorine atom into one or both fatty acid tails of GP. The detection of fluorinated metabolites and
fluorinated lipids represents a heretofore unrecognized sink for organic fluorine, an observation
with consequences for the fate and transport of fluorinated organics in environmental systems.

3.2 Introduction
A plethora of synthetic fluorinated organic chemicals are synthesized for various industrial,
military, medical, and agrochemical applications, and many are being detected in environmental
matrices including soil, groundwater, surface water, and air.1, 2 Fluorine-containing chemicals have
beneficial properties, as can be seen by the estimate that 20-30 % of modern pharmaceuticals and
agrochemicals contain fluorine.3-6 A major source of synthetic organofluorines in environmental
systems stems from the application of aqueous film-forming foams (AFFF) containing undefined
mixtures of per- and polyfluoroalkyl substances (PFAS), including fluorinated alkanes.7-9 PFAS
continue to be used, despite their drawbacks, because suitable replacements are not readily
available. The widespread use, recalcitrancy, and potential negative human health effects of
synthetic fluorinated organics, in particular PFAS, demands a detailed understanding of the fate of
these chemicals in the environment. Although most fluoroorganic chemicals in the environment
are thought to be of anthropogenic origin, natural sources exist10 and volcanic11, botanic12 and
microbial13 activities can generate fluorinated organics14, including fluorinated fatty acids15.
The strength of the carbon-fluorine bond has been used to explain why fluorinated
chemicals are generally so recalcitrant to degradation. Compared to the rich body of literature
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demonstrating biological dechlorination, similar information about defluorinating microorganisms
and defluorinating enzyme systems is limited.16-18 Although research efforts have demonstrated
that partial degradation of the fluoroorganics could occur in environment and biota, the complexity
of the fluoroorganics and the transformed products reflected in the extent of fluorination, type of
functional group and chain length difference, increases the difficulty of understanding their fate
and transport behavior in the environment.19 In the discussion of fluorinated chemicals’ fate in the
environment, biological uptake has been considered as an important sink and the accumulation has
been observed in microorganisms,20 plants,21 and animals.22 One study demonstrated that PFAS
could be non-covalently incorporated into the lipid bilayers of bacterial cells and that there is no
significant difference between PFAS accumulation in live Staphylococcus epidermidis cells versus
the dead cells. PFAS incorporation into lipids has been determined as a passive and reversible
process driven by hydrophobic and electrostatic interactions.23 The incorporation of long-chain
PFAS into phospholipids has also been reported in marine mammals, supported by the positive
correlation established between phospholipid abundance and PFAS concentration. 24 However, the
covalent incorporation of fluorinated chemicals into macromolecules in the cell has been
overlooked in previous research regarding the fate of fluoroorganics in the environment.
The soil isolate Pseudomonas sp. strain 273 utilizes terminally monofluorinated mediumchain alkanes and 1,10-difluorodecane as the sole carbon and energy source in the presence of
oxygen with the concomitant release of inorganic fluoride. Careful measurements of fluoroalkane
consumption and inorganic fluoride release reveal a discrepancy between the theoretical
organofluorine and the actual recovery of inorganic fluoride. Experimental efforts searching for
the missing fluorine have revealed the covalent incorporation of fluorine into long-chain fatty acids
and glycerophospholipids (GP). The observation that a bacterium capable of degrading fluorinated
alkanes generates fluorinated primary (central) metabolites and covalently incorporates fluorine
into macromolecules has implications for understanding and monitoring the fate of fluoroorganics
in the environment.

3.3 Materials and Methods
Chemicals.
1-Fluorodecane (FD) (purity, > 97%) was obtained from SynQuest Labs, Inc. (Alachua,
FL, USA). 1,10-difluorodecane (DFD) (> 97%) was custom-synthesized (Carbosynth, Newbury,
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UK). Sodium decanoate, sodium sebacate, sodium fluoride, sodium acetate, chloroform (> 99.8%)
and fatty acid methyl ester standards were obtained from Sigma-Aldrich (St. Louis, MO, USA).
n-Decane (decane) was obtained from Acros Organics (Fair Lawn, NJ, USA). Monofluoroacetate
(MFA) was obtained from MP Biomedicals (Solon, OH, USA). Glycerophospholipid (GP)
standards were obtained from Avanti Polar Lipids, Inc. (Alabaster, AL, USA). Ethanol, diethyl
ether, pyridine, ammonium hydroxide and methanol were obtained from Thermo Fisher Scientific
(Waltham, MA, USA). All other chemicals used were analytical reagent grade or higher, unless
otherwise specified.

Cultivation of Pseudomonas sp. strain 273.
Pseudomonas sp. strain 273 is an alkane degrader with the unique capability of degrading
terminally monohalogenated medium-chain and ,-dihalogenated alkanes under oxic
conditions.25, 26 Cultures of strain 273 were grown in defined, phosphate-buffered (pH 7.3) mineral
salt medium as described.26 The 160-mL glass serum bottles containing 50 mL medium were
closed with black butyl rubber stoppers (Bellco Glass Inc., Vineland, NJ, USA) held in place with
aluminum crimps with 110 mL air headspace. Strain 273 was maintained with different organic
compounds as the sole carbon source, including decanoate, decane, FD or DFD. The substrate
adapted cultures were obtained by transferring more than three times onto the respective carbon
substrate (i.e., decanoate, decane, FD or DFD) and were supplied as the inoculum (1%, v/v) for
the comparative analysis of metabolites (Figure 3.2). Four replicate vessels were amended with
the same (nominal) concentration (7 mM) of different C10 substrates, including decanoate, decane,
FD or DFD and received a corresponding inoculum. To ensure a sufficient supply of oxygen, the
headspace volumes were replaced daily with air. Following a 4-day incubation period, the cells
were harvested by centrifugation (8,000 x g, 15 min, room temperature) for extraction of fatty
acids and GP (Figure 3.2). To test for a possible de novo formation of C-F bonds, cultures were
grown with 7 mM (nominal) decane in the presence of 2 mM fluoride. Strain 273 was also grown
in medium with 7 mM (nominal) decane as primary substrate and 2 mM MFA. All culture bottles
were incubated in upright position at 30°C and shaken at 120 rpm.
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Fluorine mass balance.
To determine the recovery of inorganic fluoride during growth with fluoroalkanes,
quadruplicate strain 273 cultures in 160-mL glass serum bottles were supplied with 7 mM (nominal
concentrations) FD or DFD as the sole carbon and energy source. A strain 273 culture grown with
decane was used as the inoculum (1%, v/v) to avoid the introduction of inorganic fluoride. The
initial amount of neat fluoroalkane was determined gravimetrically, 11.2  0.1 mg of FD and 12.5
 0.1 mg of DFD were added to the medium initially. To ensure that oxygen was not limiting
fluoroalkane degradation, the 150-mL air headspace (~2 atm) was replaced weekly. The fluoride
and fluoroalkanes were measured after 3 weeks from the inoculation. No FD or DFD were detected
in the medium using the gas chromatography mass spectrometry (GC-MS), which suggested the
complete consumption of fluoroalkanes after the three-week incubation.

Cellular fatty acids and GP extraction.
Biomass was collected from 10 mL culture suspensions by centrifuging at 8,000 × g for 15
mins at room temperature (Sorvall RC 6 Plus Centrifuge, Thermo Fisher Scientific). Following
removal of the supernatant, the cell pellets were immediately stored at -80°C. Cellular fatty acids
were extracted and derivatized following an established protocol.26, 27 Briefly, the cells were lysed
and saponified in alkaline methanol in boiling water for 30 mins. Then the cellular fatty acids were
derivatized to fatty acid methyl esters (FAME) in acidic methanol, extracted with hexane, and
analyzed with GC-MS. GP extraction followed an established protocol with slight modifications.28
The cell pellets were washed once with sterile mineral salt medium before 1 mL of extraction
solvent composed of ethanol, Milli-Q water, diethyl ether, pyridine, and 4.2 M ammonium
hydroxide (15:15:5:1:0.8, v:v) and 100 µL of acid-washed glass beads (diameter 150-212 µm,
approximately 42,000 beads mL-1, Sigma, St. Louis, MO, USA) were added to the cell pellets. Cell
lysis was achieved by vigorously vortexing the 1.5-mL plastic tubes (Eppendorf, Hamburg,
Germany) for 20 secs. The mixtures were incubated in water bath at 60°C for 20 mins and
centrifuged at 9,600 × g for 10 mins (Sorvall Legend Micro 17, Thermo Fisher Scientific) at room
temperature. The upper organic layer of each tube was transferred to a new plastic tube and the
extraction was repeated twice. The combined organic layers were removed using a SpeedVac
vacuum concentrator (ISS110-115 Integrated, Thermo Fisher Scientific) at 43°C. The dried lipid
extracts were stored at -80°C and dissolved in 300 µL of methanol:chloroform (9:1, v:v) prior to
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liquid chromatography mass spectrometry (LC-MS) and liquid chromatography tandem mass
spectrometry (LC-MS/MS) analyses.

Enumeration of cells with quantitative PCR (qPCR).
Concomitant with the analysis of FAME and GP, 1-mL culture suspension aliquots were
passed through 0.22 μm polyvinylidene difluoride membrane filters (Merck Millipore Ltd.,
Burlington, MA, USA) to collect biomass for qPCR analysis. Genomic DNA was extracted from
the cells on the membrane filters using the DNeasy Powerlyzer PowerSoil kit (Qiagen, Hilden,
Germany) following the manufacturer’s protocol. Strain 273 16S rRNA genes were quantified
with qPCR as described.26, 29 The cell abundances were calculated by dividing the 16S rRNA gene
copy numbers by a factor of 5 to account for the five 16S rRNA genes per genome.

Analytical procedures.
FAME analysis used a Trace 1300 gas chromatograph (Thermo Fisher Scientific) equipped
with a FAMEWAX column (30 meter, 0.25 mm inner diameter, 0.25 µm film thickness, Restek,
Bellefonte, PA, USA), a Triplus RSH autosampler and an Exactive Plus Orbitrap mass
spectrometer (Thermo Fisher Scientific) with an atmospheric pressure chemical ionization
interface.30 Samples (1 µL) were injected with a 1:5 split ratio using a programmable temperature
vaporizer inlet operated at 240°C and ultra-high purity helium as carrier gas at a flow rate of 1.7
mL min-1. The initial column temperature of 80°C was held for 5 mins and increased to 240°C at
a rate of 10°C min-1. The mass spectrometer was operated in positive mode at a resolution of
140,000 scanning from 70 to 500 m/z with an automated gain control target of 3e6 and 50 msec
maximum inject time. External fatty acid methyl ester standards ranging from C4 to C23 in length
were used to verify retention times.
GP were detected using a Dionex Ultimate 3000 ultra-high performance liquid
chromatograph equipped with a Kinetex HILIC column (100 Å 2.6 µm 150 mm × 2.1 mm,
Phenomenex, Torrance, CA, USA) kept at 40°C and coupled to an Exactive Orbitrap mass
spectrometer (Thermo Fisher Scientific) as described. 31 This method separated relevant GP classes
with different headgroups, including phosphatidylethanolamine (PE), phosphatidylglycerol (PG),
phosphatidylserine

(PS),

phosphatidic

acid

(PA),

phosphatidylinositol

(PI)

and

phosphatidylcholine (PC).31 External standards including PE(32:0), PG(36:0), PI(32:0), PA(36:1),
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PS(34:2), and PC(36:0) were used to verify the retention time for each GP class. To determine the
structural configuration (i.e., headgroup, fatty acid tails length and degree of saturation) of
representative GP detected, LC-MS/MS using a Q Exactive Orbitrap mass spectrometer was
employed for targeted identification of ion fragments. The abundant lipid species detected in the
lipidome of strain 273 and the respective mono- and dual- fluorinated analogs were selected for
tandem mass spectrometry analysis.
Liquid chromatography for both LC-MS and LC-MS/MS methods used 5 mM ammonium
acetate buffer adjusted to pH of 3.0 as mobile phase A, and 97:3 (v:v) acetonitrile:water with 5
mM ammonium acetate adjusted to pH of 3.0 as mobile phase B. A Dionex UltiMate 3000 RS
autosampler kept samples at 4°C and injected 10-µL volumes for each analysis. Ionization was
performed using electrospray (voltage = 3.30 kV) with previously optimized source conditions,31
and the GP fragments representing PE, PG, PS, PA, PI were analyzed in negative mode. Only PC
was analyzed in positive mode. The Exactive Orbitrap mass spectrometer (Thermo Fisher
Scientific) was operated in full scan mode at 140,000 resolution for the LC-MS analysis. Ions with
m/z values between 100 and 1,500 were captured. Parallel reaction monitoring (PRM) mode was
used at 70,000 resolution, an isolation window of 0.6 m/z, and a normalized collisional energy of
35 for the targeted analysis.
Fluoride ions were quantified with a Dionex ICS-2100 ion chromatography system
equipped with a 4 mm × 250 mm IonPac AS18 hydroxide-selective anion-exchange column, a
Dionex potassium hydroxide eluent generator cartridge, and a conductivity detector. Fluoroalkanes
were measured in hexane extracts using an Agilent 7890A GC-MS system (Agilent, Santa Clara,
CA, USA) equipped with an autosampler, a DB-624 column and a mass-selective detector as
described.26

Data analysis.
Both FAME and GP analyses used the following criteria for analyte identification:
retention time match to the external standard (within 1 min), mass accuracy within 5 ppm of the
expected value, and peak intensities with five-fold greater area in culture samples than the
extraction solvent blank injections. The search for FAME and GP metabolites spanned carbon
chain lengths between C10 to C22 per fatty acid tail with an unsaturation degree from zero to half
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of the corresponding carbon number in fatty acid tail(s). Further, the search included one fluorine
substitution to fully fluorinated (i.e., perfluorinated) molecules.
Since standards for fluorinated FAME were not available, the retention times of the
respective non-fluorinated analogs aided identification. Atmospheric pressure chemical ionization
(APCI) was employed to predominantly generate [M+H]+, [M·]+ or [M-CH4O·]+ ions,30 and the
ionized pattern shifted drastically between FAME species. The extracted ion chromatograms (EIC)
on mass spectra were plotted using XCalibur software, version 4.0.27.19.
For GP species of strain 273 including PE, PG, PA, PI and PS, the [M-H]- dominated the
ion pool, while the PC was primarily ionized as [M+H]+. The relative abundances of different GP
were semi-quantified by the ion intensities (i.e., peak area integrated from the EIC) of [M-H]- or
[M+H]+ on Maven.32 Based on external standards, the time intervals used for peak integration for
each GP class was: PE (9.50 to 10.50 min), PG (4.50 to 5.50 min), PA (5.00 to 8.00 min), PC (11.5
to 12.5 min), PI (9.50 to 10.50 min) and PS (10.00 to 12.00 min). The abundance data represent
averages of four biological replicates. For each growth condition, the total GP abundance was
determined with equation 1. The relative abundance (in %) of GP according to different
headgroups (i.e., different classes such as PE, PG, PA, etc.), unsaturation number and fluorination
number (i.e., fluorine substitution number) were determined with equations 2 to 4. The relative
abundance (in %) of individual GP species accounting for the GP class was determined with
equation 5. The LC-MS/MS results were analyzed and plotted with Xcalibur Version 4.0.27.19.
Total GP abundance (arbitrary unit)=

Summation of peak areas of all detected GP species

Relative abundance of GP class (%)=

Summation of peak areas of GP species with the same headgroup

Cell number per mL culture

× 100 (eq. 1)

Summation of peak areas of all detected GP species

×100% (eq.

2)
Relative abundance of GP according to unsaturation (%)
=

Summation of peak areas of GP species with the same unsaturation number
Summation of peak areas of all detected GP species

×100% (eq. 3)

Relative abundance of GP according to fluorination (%)
=

Summation of peak areas of GP species with the same fluorination number
Summation of peak areas of all detected GP species

×100% (eq. 4)

Relative abundance of individual GP species accounting for the GP class (%)
The peak area of individual GP species

= Summation of peak areas of GP species with the same headgroup ×100% (eq. 5)
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Nomenclature of fatty acids and phospholipids.
In fatty acid and phospholipid designations, the first number in the bracket represents the
total number of carbons in the fatty acid chain(s) without indication of branched or linear structure,
and the second number represents the total unsaturation possession without indication of position.
The label “F” indicates fluorination, with the numeric value indicating the number of fluorine
substitutions.

3.4 Results
Fluorine mass balance in strain 273 cultures grown with fluoroalkanes.
The release of inorganic fluoride in cultures of Pseudomonas sp. strain 273 grown with
fluoroalkanes has been demonstrated.26 Efforts to determine the fluorine mass balance revealed
that not all of the organofluorine in the amounts of fluoroalkanes consumed could be accounted
for as inorganic fluoride. Following complete consumption of 6.99  0.05 mM FD, 6.44  0.12
mM of inorganic fluoride was measured in the cell-free medium (Table 3.1). Cultures that received
6.98  0.07 mM of DFD released 13.20  0.40 mM of inorganic fluoride. This careful mass balance
approach indicated that 7.8  2.2% and 5.5  2.8% of the fluorine in cultures that received FD or
DFD, respectively, was not accounted for as inorganic fluoride (Table 3.1). In several independent
experiments, the inorganic fluoride concentrations were consistently lower than those predicted
from the amounts of fluoroalkanes consumed, suggesting an unidentified sink for fluorine.

Detection of fluorinated long-chain fatty acids with FAME analysis.
The FAME analysis detected a total of 18 long-chain fatty acids (FA) with carbon numbers
greater than 10 in strain 273 cells grown with different C10 substrates (Appendix, Table S3.1). Of
the 18 long-chain fatty acids detected, seven carried a single fluorine substitution. The fluorinated
fatty acids were detected exclusively in strain 273 cells grown with FD or DFD. The FA(16:0),
FA(18:1), FA(16:1), FA(19:1) and FA(17:1) were detected as the top five fatty acids with the
highest ion intensity in cells grown with decane, FD and DFD (Figure 3.3). FA(16:0)-F was
detected in cells during growth with fluoroalkanes, and higher ion intensities were obtained with
cells grown with DFD than with FD. In addition to FA(16:0)-F, FA(18:1)-F, FA(16:1)-F,
FA(17:1)-F and FA(19:1)-F were observed in strain 273 cells grown with DFD. Fluorinated fatty
acids with more than a single fluorine substitution were not detected under any growth condition.
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The FAME species with or without fluorine substitution ionized differently during APCI,
and the most responsive ions, [M+H]+ and [M•]+ varied for the different (fluorinated) analytes
(Table S3.1). For example, in strain 273 cells grown with DFD, the [M+H]+ ions of FA(16:0) and
FA(16:0)-F exhibited peak areas of (2.2 ± 0.4) × 105 and (1.3 ± 0.3) × 104, respectively, whereas
the peak areas for the [M•]+ ions were (9.9 ± 4.2) × 104 and (2.8 ± 1.3) × 105, respectively (Figure
3.4 and Table S3.1). Table S3.1 lists peak areas for the [M+H]+, [M•]+ or [M-CH4O]+ ions of the
18 long-chain fatty acids identified. Due to the varied ionization responses, the quantitative ion
species was not consistent among all FAME species, therefore prohibiting a quantitative
comparison among FAME species.

Comparative lipidomics analyses of strain 273 cells grown with different carbon substrates.
Lipidome analysis identified a total of 165 GP species, distributed among 5 GP classes
including PE (86 distinct species), PG (43), PA (23), PS (8) and PC (5), that were detected in strain
273 cells (Table S3.2). The relative GP abundances in strain 273 cells grown with decane,
decanoate, FD, or DFD were 3.77 ± 0.97 (arbitrary unit, AU), 3.65 ± 0.63, 4.35 ± 0.70, and 4.54
± 0.92, respectively (Figure 3.5). When strain 273 cells were grown with decane, FD, or DFD, PE
and PG accounted for over 99% of all GP (Figure 3.5 A). When decanoate was supplied as a
growth substrate, 9.4 ± 1.7% of the total GP were PC. In contrast, PC accounted for less than 0.02%
of total GP when decane, FD or DFD were supplied as growth substrates. A higher relative
abundance of PA was observed in decanoate-grown cells (2.1 ± 1.0%) compared to (fluoro)alkanegrown cells (0.2 to 0.7%). PS were barely detectable (< 0.2%) under all growth conditions, and PI
were not detected.
Over half of the GP in strain 273 cells contained one unsaturation in the one of acyl chains
under all growth conditions (Figure 3.5 B). Interestingly, about 1.2 ± 0.6% of the GP were polyunsaturated (unsaturation number > 2) when strain 273 was grown with DFD, but less than 0.02%
of poly-unsaturated glycerophospholipids were detected in cultures grown with the other substrates.
Fluorinated GP were exclusively detected in strain 273 cells grown with fluoroalkanes (i.e., FD or
DFD) (Figure 3.5 C). Approximately, 8.4 ± 1.3% and 43.9 ± 8.8% of GP comprised one fluorine
substitution when strain 273 cells were grown with FD or DFD, respectively (Figure 3.5 C). The
abundances of GP with two fluorine substitutions were 0.1 ± 0.0% and 46.8 ± 10.4%, respectively,
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in cells grown with FD and DFD. GP with more than two fluorine substitutions (fluorination
number > 2) were not detected.
The analysis revealed the relative abundances of PE and PG species resolved by acyl chain
carbon number and unsaturation number in cells of strain 273 grown with different carbon
substrates. Regardless of fluorine substitution, the relative abundances of PE and PG species were
distributed in a similar pattern in strain 273 cells grown with decane, FD, DFD or decanoate
(Figure 3.5). The majority (> 92%) of PE and PG species comprised 32 to 36 carbon atoms in their
two acyl tails and the most abundant PE and PG species were PE(34:1) and PG(34:1), respectively.
In strain 273 cells grown with FD, 9.8 ± 0.1% of PE and 6.4 ± 0.4% of PG were fluorinated.
Substantially larger percentages of PE (91.5 ± 1.3%) and of PG (87.0 ± 2.0%) were fluorinated in
strain 273 cells grown with DFD. A principal component analysis (PCA) of the lipidome data
clearly distinguished strain 273 cells grown with DFD from cells grown with other substrates,
presumably due to the higher abundance of fluorinated GP (Appendix, Figure S3.1).
Strain 273 was not able to grow with MFA as the sole carbon source; however, some cometabolic consumption of MFA was observed in cultures with decane provided as a primary
substrate. In cells of strain 273 grown with decane (7 mM, nominal) in the presence of 2 mM MFA,
about 2.1 ± 0.1% and 2.0 ± 0.2% of PE and PG, respectively, were fluorinated. This finding
demonstrates co-metabolism of MFA and fluorine incorporation into GP, although the degree of
fluorine incorporation was low compared to FD- and DFD-grown cells (Figure 3.6). All fluorinated
lipid species detected in MFA/decane-grown cells could also be detected in FD- or DFD-grown
cells.
Fluorinated GP were detected exclusively in strain 273 cells when the growth medium had
been supplied with FD, DFD or MFA. No fluorinated GP (< 0.01%) were detected in strain 273
cells grown in medium with 7 mM (nominal) decane and amended with 2 mM inorganic fluoride.
Covalent incorporation of fluorine into acyl chains of GP.
In the lipidome of strain 273, the most abundant lipid species were PE(34:1) and PG(34:1)
(Figure 3.5 D,E). The fluorinated analogs with one or two fluorine substitution(s) were detected
when fluorinated alkanes (i.e., FD or DFD) served as growth substrates. The structure of PE(34:1)
and the corresponding fluorinated analogs were prospected by LC-MS/MS analysis (Figure 3.7).
The fragmentation pattern of PE (34:1) (m/z of [M-H]- = 716.5236) revealed ions of ethanolamine
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phosphate, and FA(16:0) and FA(18:1) acyl chains (Figure 3.7 A). The LC-MS/MS analysis
determined the configuration of the abundant PE(34:1) species, which was composed of one
FA(16:0) and one FA(18:1) attached to a glycerol with ethanolamine phosphate as the headgroup
(Figure 3.7 A). This observation is consistent with the FAME results that measured FA(16:0) and
FA(18:1) in strain 273 cells (Figure 3.3). In the fragments of the mono-fluorinated analog PE
(34:1)-F (m/z of [M-H]- = 734.5142), the fragment ions representing ethanolamine phosphate,
FA(16:0), FA(16:0)-F, FA(18:1), and FA(18:1)-F were all identified. The LC-MS/MS analysis
revealed isomers of PE(34:1)-F with distinct fatty acid tail combinations (Figure 3.7 B). Fluorine
substitution of PE(34:1)-F occurred on either fatty acid tail but not on the glycerol moiety or the
headgroups (e.g., ethanolamine). In the fragments of the dual-fluorinated analog PE(34:1)-2F (m/z
of [M-H]- = 734.5142), the fragment ions of ethanolamine phosphate, FA(16:0)-F and FA(18:1)F were identified. Noteworthy, dual-fluorinated fatty acid ions, for example FA(16:0)-2F (m/z =
281.2481) and FA(18:1)-2F (m/z = 317.2292) ions, were not identified, indicating that the dualfluorinated PE(34:1)-2F contained two fatty acid tails each with one covalently incorporated
fluorine atom (Figure 3.7 B). The FAME data supported this conclusion and provided no evidence
for polyfluorinated fatty acids in cells of strain 273 grown with fluorinated alkanes. In addition,
the fragment analyses of PG(34:1), PG(34:1)-F and PG(34:2)-2F demonstrated a similar fluorine
substitution pattern, corroborating the conclusion that no dual-fluorinated fatty acids were
produced (Figure S3.2). The described fragment patterns were consistent and observed in all four
replicate cultures.

3.5 Discussion
The GP composition differs in Pseudomonas sp. strain 273 cells grown with fluoroalkanes
versus decane.
The distribution of GP profiles at the class level are conserved among different
Pseudomonas spp., and PE and PG classes account for around 95% of the total GP. 33-35 In strain
273, PE and PG accounted for over 99% of the total GP when (fluoro)alkanes were supplied as the
sole electron donor and carbon source. The GC-MS-based FAME analysis detected fatty acids
with 16 or 18 carbon atoms, and the LC-MS-based lipidomics analysis determined that over 92%
of GP in strain 273 contained 32 to 36 carbons in the two fatty acid tails combined. Similar
observations were made in cells of Pseudomonas putida grown with butanol and the majority (>
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93%) acyl chains in GP molecules comprised 16 or 18 carbons.33 Regardless of fluorine
substitution, the GP component of strain 273 cells grown with decane, FD, DFD or decanoate were
similar to those reported for other Pseudomonas spp.
The incorporation of halogens into lipids is not unprecedented and the formation of
iodinated, brominated and chlorinated lipids has been reported in Rhodococcus rhodochrous strain
NCIMB 13064. During growth of strain NCIMB 13064 with medium- to long-chain 1-chloro-, 1bromo-, and 1-iodo-alkanes, up to 75%, 90%, and 81% of the total fatty acids were substituted in
the ω-position by the corresponding halogen, respectively.36 Interestingly, this bacterium could
utilize 1-fluorotetradecane as a growth substrate but no fluoride was released and the
corresponding fluorinated C14 fatty acid represented only 1% of the total fatty acids. 36, 37 Growth
of Pseudomonas sp. strain 273 with 1-fluorotetradecane as the sole carbon substrate was associated
with fluoride release highlighting the distinct defluorination capabilities of strain 273 (unpublished
data).

Fluorinated GP synthesis in strain 273.
Fluorinated GP were detected in membrane lipids only when strain 273 was grown with
fluorinated organic compounds (i.e., FD, DFD) as the sole carbon and energy source. Fluorinated
GP were also detected in strain 273 cells that co-metabolized MFA with decane as a primary
substrate. Growth of strain 273 in medium amended with non-fluorinated substrates and inorganic
fluoride did not result in the formation of fluorinated GP, suggesting that the organisms cannot
form C-F bonds using inorganic fluoride under the growth conditions employed.
A previous study detected ω-fluorofatty acids with chain lengths of C6, C8 and C10 during
growth of strain 273, with fluoroalkanes suggesting catabolism via β-oxidation and the formation
of ω-fluorofatty acyl-CoA metabolites.26 The current study expands these observations and
detected fluorofatty acids with carbon chain lengths greater than ten (i.e., C 12 to C18), suggestive
of fluorofatty acid elongation (Figure 3.8). Only long-chain fatty acids with single fluorine
substitution were detected in cells grown with fluoroalkanes. A plausible explanation is a catabolic
route via β-oxidation leading to the formation of MFA-CoA, which could be a precursor to the
MFA-acyl carrier protein (ACP) and serve as the initiating unit in long-chain fatty acid synthesis.
Such a process would explain the formation of -fluorinated long-chain fatty acids, as was
observed in strain 273 grown with FD and DFD. The detection of fluorinated GP in cells grown in
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the presence of MFA as the sole fluorine source indicated that strain 273 can transport MFA inside
the cell, activate MFA to MFA-CoA, and channel MFA-CoA into fatty acid biosynthesis. MFA
was co-metabolized and did not support growth without a primary substrate (e.g., decane).
Substantially less fluorinated GP were detected in cells grown in the presence of MFA compared
to cells grown with FD or DFD. Possible explanations for these observations include inefficient
transport of MFA across the cytoplasmic membrane or inefficient conversion of MFA to MFACoA. Of note, strain 273 readily utilizes acetate as the sole source of carbon and energy.
In each iterative elongation cycle, two carbon atoms, with one of them potentially carrying
a fluorine, are added to the fatty acyl-ACP (Figure 3.8). While monofluorinated fatty acids were
highly abundant, the absence of the polyfluorinated fatty acid can be explained by the inability of
converting MFA-CoA into fluoromalonyl-ACP or the exclusion of fluoromalonyl-ACP from the
acyl chain elongation (See Figure 3.8 for details).38 The similar observation that no more than one
fluorine substitution on a fatty acid was made in other organisms that are capable of generating CF bonds using inorganic fluoride.39
The product of the fatty acid biosynthesis, predominantly the C16 and C18 fatty acids, would
be esterified with glycerol-3-phosphate catalyzed by an acyltransferase leading to the formation of
PA, a precursor for GP synthesis. The consistent percentage of fluorinated lipids in both PE and
PG suggests that GP transformation into different classes showed no preference for fluorinated
precursors. The predominant GP classes, PE and PG, accounted for similar relative abundances in
cells grown with fluorinated alkanes versus decane, suggesting that fluorometabolites do not
influence headgroup transformation of GP.
The observed assimilation of fluorine into GP suggests enzyme promiscuity in anabolic
pathways, as strain 273 enzyme systems apparently involved in long-chain fatty acid and GP
biosynthesis do not discriminate between fluorinated and non-fluorinated metabolites. Fluorine
and hydrogen atoms are similar in size, which can lead to enzyme promiscuity.40 For instance,
Escherichia coli adapted to utilizing fluorinated precursors (i.e., fluoroindole) produced
fluorotryptophan rather than tryptophan and assimilated the fluorinated amino acid into the cellular
proteome.41
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Impact of fluorine incorporation for the bacterium.
The impact of fluorination on the functionality of the cellular membrane and the organism
is uncertain. The artificial assembly of a GP bilayer comprising 1-palmitoyl-2-[16fluoropalmitoyl]-phosphatidylcholine (F-DPPC), which has one fatty acid tail with a terminal
fluorine substitution, preferentially formed interdigitated layers at the gel phase, causing the
membrane phase transition temperature to increase by 10°C compared to a bilayer of the
nonfluorinated analog.42 In vivo study with Escherichia coli strain K1060B5 has demonstrated that
up to 50 mol % of exogenously supplied geminal difluoromethylene fatty acids (i.e., 8,8difluoromyristyic acid) could be incorporated into membrane fatty acids. 43 Altered lipid/protein
ratios, modified transport of methyl β-D-thiogalactopyranoside, and reduced growth rate were
observed when 20 mol % of fatty acids in cells of strain K1060B5 were fluorinated.44 Conversely,
Acholeplasma laidlawii strain B could incorporate exogenously supplied monofluorinated fatty
acids including 5-fluoro-, 8-fluoro-, 14-fluoro-palmitic acid up to 80 mol % of membrane fatty
acids with no effect on lipid/protein ratios and growth yields. 45, 46 Strain 273 could incorporate
fluorine into GP accounting for up to 90.7% of the total GP when cells utilized DFD as a growth
substrate. Strain 273 could be repeatedly transferred in medium supplied with DFD as the sole
carbon and energy source without apparent negative impact on growth. The GP profiling
determines cell membrane fluidity and permeability, which can alter in response to the chemical
stress.47 The fluoride can induce the oxidative stress and apoptosis toxic effect and the fluorolipid
may impact the membrane function.48 The increased abundance of polyunsaturated GP in cells
grown with DFD could be considered as a defensive mechanism against the stress induced by the
fluorinated lipids assimilation and the fluoride release. 49 More detailed studies are warranted to
explore the consequences of fluorine incorporation for cell function and behavior.

Implications for tracing the fate of organofluorine compounds.
Studies focused on measuring fluoroorganics use optimized workflows to recover the
analyte(s) of interest from environmental matrices (e.g., soil, sediment, aquifer material, sludge,
or groundwater), or from tissue and blood samples of animals and humans. These measurements
provide an assessment of the concentrations or amounts of fluorinated target analyte(s) associated
with environmental system under study. The observation that fluorinated alkanes can be
transformed and fluorinated metabolites channeled into anabolic pathways for fatty acid
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biosynthesis, as demonstrated for Pseudomonas sp. strain 273, may present a relevant sink for
fluorine. The experimental efforts with strain 273 demonstrated that 44% and 47% of GP
comprised one and two fluorine substitution(s), respectively, following growth with DFD. Based
on the generic number of 2.2 × 107 GP molecules per cell (i.e., 3.7 × 10-17 mol / cell)50, we calculate
that a single cell can incorporate 5.04 × 10-11 µmol of F cell-1 (or 5.04 × 10-8 nmol of F cell-1). The
fate of the fluorinated fatty acids following cell death is unclear, but it is likely that other
microorganisms utilize fluorinated metabolites as precursors for anabolic purposes. In such a
scenario, more widespread fluorine incorporation in microbial cells would be predicted in
environments impacted with, for example, AFFF. Considering that 1 g of soil (dry weight) harbors
1.5 × 1010 bacterial cells51, microbial biomass may represent a major, heretofore unrecognized sink
for organofluorine.
It is currently unknown whether eukaryotic cells incorporate fluorine via anabolic routes;
however, circumstantial evidence suggests that this may be the case. PFAS are globally distributed
and have been detected and quantified in various mammal species, including humans.52-54
Following solvent extraction of organofluorine and subsequent analysis of PFAS in mammalian
tissue or blood samples, substantial differences between the total fluorine (as fluoride determined
by combustion ion chromatography) and measurable organofluorine compounds (e.g., PFAS)
(determined by LC-MS) were reported.55-57 These observations hint at unidentified sources of
fluorinated compounds in mammals, and the incorporation of fluorine in cellular macromolecules
via anabolic routes, as described here for a bacterium, should be considered.
Notably, despite our efforts to account for the fluorine incorporated into cellular
membranes in strain 273 cultures, the fluorine mass balance could not be closed. Based on the
experimental data, a single strain 273 cell incorporated about 5 × 10 -11 µmol of F. The culture
receiving 350 µmol of DFD yielded 5.6 ×1010 cells (1.12 ×109 cells mL-1) (Table S3.3). Thus,
fluorine incorporation into lipids accounted for approximately 2.82 µmol of F or 0.4% of the
fluorine in the growth substrate DFD. Considering that 5.5 ± 2.8 % of the fluorine could not be
accounted for, the observation that merely 0.4% of the fluorine was associated with the membrane
assimilation suggests that other cellular sinks exist. The assimilation of fluorine into the
macromolecules, a novel and heretofore not recognized sink for fluorine, can significantly
influence fluorinated chemicals’ fate and transport behavior in the environment.
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Figure 3. 1. Graphical abstract of research contents in chapter 3.
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Figure 3. 2. Schematic overview of experimental design in chapter 3. Strain 273 was transferred
three times onto respective carbon substrate prior to the inoculation for substrate-comparative
FAME and lipidomics analyses. Fatty acids and glycerophospholipids extracted from the same
culture were analyzed by GC- and LC- mass spectrometry, respectively. Each growth condition
had four biological replicates.
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Figure 3. 3. The combined extracted ion chromatograms (EIC) of the top five abundant fatty acids
and their fluorinated analogs detected in cells of 273 grown with different carbon substrates
including decane, FD, DFD, and decanoate. The most responsive ion of each FAME species was
selected and graphed. The inset represents the magnified view of EIC.
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Figure 3. 4. Combined extracted ion chromatograms (EIC) of FA(16:0) and FA(16:0)-F in
different ionization forms as [M•]+ and [M+H]+ detected in DFD grown cells.
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Figure 3. 5. Lipidome profiles of strain 273 grown with different C10 substrates including decane,
FD, DFD or decanoate, respectively. Glycerophospholipid distributions are illustrated in (A)
classes with different headgroups, (B) unsaturation number, (C) fluorine substitution number; and
relative abundance of individual (D) PE and (E) PG species with relative abundances higher than
2%.
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Figure 3. 6. The extracted ion chromatogram of PE(34:1)-F (m/z of [M-H]- = 734.5136) detected
in cells of strain 273 grown with different carbon sources including: FD, MFA/decane,
fluoride/decane, and decane.
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Figure 3. 7. LC-MS/MS-based fragment analysis of (A) PE(34:1), (B) PE(34:1)-F and (C)
PE(34:1)-2F in lipid extracts from strain 273 cells grown with DFD. Ion fragments associated with
the target molecules are presented as headgroup (H), carbon number (C), unsaturation number (U)
and fluorine substitution number (F). The detected ion fragments are shown in black font while
undetected fragments are illustrated in red font. The inset represents the magnified view of the
tandem MS result.
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Figure 3. 8. Proposed catabolic and anabolic pathways for fluoroalkane turnover in Pseudomonas
sp. strain 273. The heatmap illustrates metabolites identified in cells of strain 273 grown with
decanoate, decane, FD and DFD,. The blue circles highlight carbon atoms that would be
assimilated into the fatty acid chain in each iterative elongation cycle, which consumes one
malonyl-ACP.
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Figure S3. 1. Principal component analysis of lipidomes of strain 273 cells grown with decane,
decanoate, FD or DFD. Each colored circle represents one of four replicate cultures.
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Figure S3. 2. LC-MS/MS-based fragment analysis of (A) PG(34:1), (B) PG(34:1)-F and (C)
PG(34:1)-2F in cells of strain 273 grown with DFD. Ion fragments associated with the target
molecules are presented as headgroup (H), carbon number (C), unsaturation number (U) and
fluorine substitution number (F). The detected ion fragments are shown in black font while
undetected fragments are depicted in red font. The inset displays the magnified view of tandem
MS result.
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Table 3. 1. Fluorine mass balances in Pseudomonas sp. strain 273 cultures grown with FD and
DFD.

a

Substrate

Initial Amount
(mM, nominal)

Total Fluorine Fluoride
(mM)
Released
(mM) a

Unaccounted
Fluorine (mM) b

Fluorine
Unaccounted
(%) c

FD

6.99 ± 0.05

6.99 ± 0.05

6.44 ± 0.12

0.55 ± 0.16

7.8 ± 2.2

DFD

6.98 ± 0.07

13.97 ± 0.14

13.20 ± 0.40

0.77 ± 0.39

5.5 ± 2.8

Inorganic fluoride concentrations were measured 3 weeks after inoculation, when fluoroalkanes

had been completely consumed.
b

The amount of fluorine unaccounted for represents the difference between the total fluorine

introduced with the fluorinated growth substrate and the total amount of inorganic fluoride released.
c

Unaccounted Fluorine (%) =

Fluorine Unaccounted (mM)
Total Fluorine (mM)

× 100

The data represent the averages and the standard deviations of four replicate cultures.
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Table S3. 1. List of long-chain fatty acid methyl esters (FAME) detected in cells of strain 273
grown with decanoate, decane, FD or DFD. The peak areas of each FAME in different ionization
forms are listed. Each data set represents the average of four replicate extractions. The most
responsive ion with the highest signal response for each FAME species is highlighted in light blue.
Compound

Formula
(as M)

FA(12:0)MethylEster
FA(12:0)MethylEster
FA(12:0)MethylEster
FA(12:0)-FMethylEster
FA(12:0)-FMethylEster
FA(12:0)-FMethylEster
FA(14:0)MethylEster
FA(14:0)MethylEster
FA(14:0)MethylEster
FA(16:0)MethylEster
FA(16:0)MethylEster
FA(16:0)MethylEster
FA(16:0)-FMethylEster
FA(16:0)-FMethylEster
FA(16:0)-FMethylEster
FA(16:1)MethylEster
FA(16:1)MethylEster
FA(16:1)MethylEster
FA(16:1)-FMethylEster
FA(16:1)-FMethylEster
FA(16:1)-FMethylEster
FA(17:1)MethylEster
FA(17:1)MethylEster
FA(17:1)MethylEster
FA(17:1)-FMethylEster
FA(17:1)-FMethylEster
FA(17:1)-FMethylEster
FA(18:0)MethylEster
FA(18:0)MethylEster
FA(18:0)MethylEster
FA(18:0)-FMethylEster
FA(18:0)-FMethylEster
FA(18:0)-FMethylEster

C13H26O2
C13H26O2
C13H26O2
C13H25O2F
C13H25O2F
C13H25O2F
C15H30O2
C15H30O2
C15H30O2
C17H34O2
C17H34O2
C17H34O2
C17H33O2F
C17H33O2F
C17H33O2F
C17H32O2
C17H32O2
C17H32O2
C17H31O2F
C17H31O2F
C17H31O2F
C18H34O2
C18H34O2
C18H34O2
C18H33O2F
C18H33O2F
C18H33O2F
C19H38O2
C19H38O2
C19H38O2
C19H37O2F
C19H37O2F
C19H37O2F

Reten
tion
Time
(min)
10.48
10.48
10.51
13.30
13.31
13.31
12.81
12.81
12.84
14.82
14.82
14.82
17.11
17.08
15.03
15.03
15.03
17.26
15.97
15.96
15.96
18.13
18.12
18.12
16.64
16.64
16.66
18.64
18.73
18.73

Peak Area
Ion Type

Decan
oate

Decan
e

FD

DFD

M+H
M
M-CH4O
M+H
M
M-CH4O
M+H
M
M-CH4O
M+H
M
M-CH4O
M+H
M
M-CH4O
M+H
M
M-CH4O
M+H
M
M-CH4O
M+H
M
M-CH4O
M+H
M
M-CH4O
M+H
M
M-CH4O
M+H
M
M-CH4O

1.8E+6
3.6E+5
0.0E+0
0.0E+0
0.0E+0
0.0E+0
3.9E+5
1.4E+5
0.0E+0
8.4E+6
4.9E+6
1.3E+4
0.0E+0
0.0E+0
0.0E+0
1.8E+6
2.7E+5
7.0E+5
0.0E+0
0.0E+0
0.0E+0
1.5E+6
2.4E+5
4.5E+5
0.0E+0
0.0E+0
0.0E+0
1.3E+5
1.1E+5
1.3E+2
0.0E+0
0.0E+0
0.0E+0

0.0E+0
2.2E+4
0.0E+0
0.0E+0
1.2E+2
8.9E+1
0.0E+0
0.0E+0
0.0E+0
8.2E+5
5.1E+5
2.6E+2
0.0E+0
0.0E+0
0.0E+0
1.9E+5
2.4E+4
6.6E+4
0.0E+0
0.0E+0
0.0E+0
1.1E+5
1.6E+4
3.5E+4
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0

0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
6.4E+5
3.9E+5
0.0E+0
0.0E+0
9.6E+3
0.0E+0
1.7E+5
2.1E+4
6.1E+4
4.8E+2
0.0E+0
0.0E+0
7.1E+4
1.0E+4
2.4E+4
1.1E+2
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0

0.0E+0
0.0E+0
0.0E+0
0.0E+0
3.5E+3
0.0E+0
0.0E+0
0.0E+0
0.0E+0
2.2E+5
9.9E+4
0.0E+0
1.3E+4
2.8E+5
0.0E+0
3.7E+4
2.0E+3
8.6E+3
3.1E+4
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
1.8E+4
1.7E+2
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
1.0E+4
0.0E+0
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Table S3.1 continued
Compound

Formula
(as M)

FA(18:1)MethylEster
FA(18:1)MethylEster
FA(18:1)MethylEster
FA(18:1)-FMethylEster
FA(18:1)-FMethylEster
FA(18:1)-FMethylEster
FA(19:0)MethylEster
FA(19:0)MethylEster
FA(19:0)MethylEster
FA(19:1)MethylEster
FA(19:1)MethylEster
FA(19:1)MethylEster
FA(19:1)-FMethylEster
FA(19:1)-FMethylEster
FA(19:1)-FMethylEster
FA(21:5)MethylEster
FA(21:5)MethylEster
FA(21:5)MethylEster
FA(21:6)MethylEster
FA(21:6)MethylEster
FA(21:6)MethylEster

C19H36O2
C19H36O2
C19H36O2
C19H35O2F
C19H35O2F
C19H35O2F
C20H40O2
C20H40O2
C20H40O2
C20H38O2
C20H38O2
C20H38O2
C20H37O2F
C20H37O2F
C20H37O2F
C22H34O2
C22H34O2
C22H34O2
C22H32O2
C22H32O2
C22H32O2

Reten
tion
Time
(min)
16.82
16.82
16.82
18.92
18.91
18.91
17.48
17.48
17.47
17.70
17.71
17.71
19.74
19.74
19.89
18.91
18.91
18.89
18.92
-

Peak Area
Ion Type

Decan
oate

Decan
e

FD

DFD

M+H
M
M-CH4O
M+H
M
M-CH4O
M+H
M
M-CH4O
M+H
M
M-CH4O
M+H
M
M-CH4O
M+H
M
M-CH4O
M+H
M
M-CH4O

3.2E+6
7.1E+5
1.4E+6
0.0E+0
0.0E+0
0.0E+0
1.1E+2
0.0E+0
0.0E+0
1.9E+6
4.0E+5
7.1E+5
0.0E+0
0.0E+0
2.5E+2
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0

4.1E+5
8.7E+4
1.6E+5
0.0E+0
0.0E+0
0.0E+0
0.0E+0
1.1E+2
0.0E+0
1.3E+5
2.7E+4
4.8E+4
0.0E+0
0.0E+0
2.0E+2
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0

2.5E+5
5.5E+4
1.0E+5
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
6.5E+4
1.2E+4
2.2E+4
0.0E+0
0.0E+0
0.0E+0
0.0E+0
0.0E+0
1.2E+2
0.0E+0
0.0E+0
0.0E+0

2.1E+5
3.5E+4
6.2E+4
1.0E+5
7.4E+2
3.3E+2
0.0E+0
0.0E+0
0.0E+0
3.6E+4
4.9E+3
9.4E+3
1.7E+4
1.2E+2
1.6E+2
2.0E+3
0.0E+0
0.0E+0
2.2E+3
0.0E+0
0.0E+0
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Table S3. 2. List of glycerophospholipids including PE, PG, PA, PS and PC detected in cells of
strain 273 grown with decanoate, decane, FD or DFD.

Compound

Formula

PE(26:1)
PE(27:1)
PE(28:0)
PE(28:0)-1F
PE(28:0)-2F
PE(28:1)
PE(28:1)-1F
PE(28:1)-2F
PE(28:2)-1F
PE(29:1)
PE(29:1)-1F
PE(29:1)-2F
PE(29:2)-1F
PE(30:0)
PE(30:0)-1F
PE(30:0)-2F
PE(30:1)
PE(30:1)-1F
PE(30:1)-2F
PE(30:2)
PE(30:2)-1F
PE(31:0)
PE(31:1)
PE(31:1)-1F
PE(31:1)-2F
PE(31:2)-1F
PE(32:0)
PE(32:0)-1F
PE(32:0)-2F
PE(32:0)-3F
PE(32:1)
PE(32:1)-1F
PE(32:1)-2F
PE(32:2)
PE(32:2)-1F
PE(32:2)-2F
PE(33:0)-1F

C31H60NO8P
C32H62NO8P
C33H66NO8P
C33H65NO8PF
C33H64NO8PF2
C33H64NO8P
C33H63NO8PF
C33H62NO8PF2
C33H61NO8PF
C34H66NO8P
C34H65NO8PF
C34H64NO8PF2
C34H63NO8PF
C35H70NO8P
C35H69NO8PF
C35H68NO8PF2
C35H68NO8P
C35H67NO8PF
C35H66NO8PF2
C35H66NO8P
C35H65NO8PF
C36H72NO8P
C36H70NO8P
C36H69NO8PF
C36H68NO8PF2
C36H67NO8PF
C37H74NO8P
C37H73NO8PF
C37H72NO8PF2
C37H71NO8PF3
C37H72NO8P
C37H71NO8PF
C37H70NO8PF2
C37H70NO8P
C37H69NO8PF
C37H68NO8PF2
C38H75NO8PF

Ionized
Species
[M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H][M-H]-

Detected
m/z of
the ion
604.40
618.41
634.45
652.44
670.43
632.43
650.42
668.41
648.40
646.45
664.44
682.43
662.42
662.48
680.47
698.46
660.46
678.45
696.44
658.45
676.44
676.49
674.48
692.47
710.46
690.45
690.51
708.50
726.49
744.48
688.49
706.48
724.47
686.48
704.47
722.46
722.51

Exact
m/z of
the ion
604.40
618.41
634.44
652.44
670.43
632.43
650.42
668.41
648.40
646.44
664.44
682.43
662.42
662.48
680.47
698.46
660.46
678.45
696.44
658.44
676.44
676.49
674.48
692.47
710.46
690.45
690.51
708.50
726.49
744.48
688.49
706.48
724.47
686.48
704.47
722.46
722.51

∆MS(ppm)
0.77
1.16
0.97
1.29
0.54
0.74
0.91
0.77
0.52
1.42
0.96
1.70
0.89
0.78
1.97
0.80
0.86
0.57
0.45
0.94
0.65
1.87
0.47
0.78
0.37
1.43
1.47
1.19
0.09
1.32
0.82
1.26
0.57
0.90
0.91
0.64
1.65
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Compound
PE(33:1)
PE(33:1)-1F
PE(33:1)-2F
PE(33:2)
PE(33:2)-1F
PE(33:2)-2F
PE(34:0)-1F
PE(34:0)-2F
PE(34:1)
PE(34:1)-1F
PE(34:1)-2F
PE(34:2)
PE(34:2)-1F
PE(34:2)-2F
PE(34:3)
PE(34:3)-1F
PE(35:1)
PE(35:1)-1F
PE(35:1)-2F
PE(35:2)
PE(35:2)-1F
PE(35:2)-2F
PE(35:4)
PE(35:4)-1F
PE(35:5)
PE(35:5)-1F
PE(35:6)
PE(36:1)
PE(36:1)-1F
PE(36:1)-2F
PE(36:2)
PE(36:2)-1F
PE(36:2)-2F
PE(36:5)
PE(36:5)-1F
PE(36:6)
PE(37:2)
PE(37:2)-1F
PE(37:2)-2F

Table S3.2 continued
Detected
Ionized
Formula
m/z of
Species
the ion
[M-H]702.51
C38H74NO8P
[M-H]720.50
C38H73NO8PF
738.49
C38H72NO8PF2 [M-H][M-H]700.49
C38H72NO8P
[M-H]718.48
C38H71NO8PF
736.47
C38H70NO8PF2 [M-H][M-H]736.53
C39H77NO8PF
754.52
C39H76NO8PF2 [M-H][M-H]716.52
C39H76NO8P
[M-H]734.51
C39H75NO8PF
[M-H]752.50
C39H74NO8PF2
[M-H]714.51
C39H74NO8P
[M-H]732.50
C39H73NO8PF
750.49
C39H72NO8PF2 [M-H][M-H]712.49
C39H72NO8P
[M-H]730.48
C39H71NO8PF
[M-H]730.54
C40H78NO8P
[M-H]748.53
C40H77NO8PF
766.52
C40H76NO8PF2 [M-H][M-H]728.52
C40H76NO8P
[M-H]746.51
C40H75NO8PF
764.51
C40H74NO8PF2 [M-H][M-H]724.49
C40H72NO8P
[M-H]742.48
C40H71NO8PF
[M-H]722.48
C40H70NO8P
[M-H]740.47
C40H69NO8PF
[M-H]720.46
C40H68NO8P
[M-H]744.56
C41H80NO8P
[M-H]762.55
C41H79NO8PF
780.54
C41H78NO8PF2 [M-H][M-H]742.54
C41H78NO8P
[M-H]760.53
C41H77NO8PF
778.52
C41H76NO8PF2 [M-H][M-H]736.49
C41H72NO8P
[M-H]754.48
C41H71NO8PF
[M-H]734.48
C41H70NO8P
[M-H]756.55
C42H80NO8P
[M-H]774.55
C42H79NO8PF
792.54
C42H78NO8PF2 [M-H]-

Exact
m/z of
the ion
702.51
720.50
738.49
700.49
718.48
736.47
736.53
754.52
716.52
734.51
752.50
714.51
732.50
750.49
712.49
730.48
730.54
748.53
766.52
728.52
746.51
764.50
724.49
742.48
722.48
740.47
720.46
744.55
762.54
780.54
742.54
760.53
778.52
736.49
754.48
734.48
756.55
774.54
792.54

∆MS(ppm)
1.16
2.14
0.63
0.95
1.38
1.24
3.58
1.81
1.77
1.08
0.41
0.86
0.74
-0.32
0.94
1.08
2.08
1.26
0.73
0.92
0.66
2.24
2.03
2.01
1.82
2.48
3.29
2.64
1.43
1.17
0.70
0.58
0.21
0.50
2.37
2.61
0.35
0.76
0.52
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Compound
PE(37:5)
PE(37:5)-1F
PE(37:6)
PE(37:6)-1F
PE(38:2)
PE(38:2)-1F
PE(38:5)-1F
PE(38:6)
PE(38:6)-1F
PE(39:6)
PG(26:0)
PG(28:0)
PG(30:0)
PG(30:0)-1F
PG(30:0)-2F
PG(30:1)
PG(31:1)
PG(32:0)
PG(32:0)-1F
PG(32:0)-2F
PG(32:1)
PG(32:1)-1F
PG(32:1)-2F
PG(32:2)
PG(32:2)-1F
PG(32:2)-2F
PG(33:1)
PG(33:1)-1F
PG(33:1)-2F
PG(33:2)
PG(33:2)-1F
PG(33:2)-2F
PG(34:1)
PG(34:1)-1F
PG(34:1)-2F
PG(35:1)
PG(35:1)-1F
PG(35:1)-2F
PG(35:2)

Table S3.2 continued
Detected
Ionized
Formula
m/z of
Species
the ion
[M-H]750.51
C42H74NO8P
[M-H]768.50
C42H73NO8PF
[M-H]748.49
C42H72NO8P
[M-H]766.48
C42H71NO8PF
[M-H]770.57
C43H82NO8P
[M-H]788.56
C43H81NO8PF
[M-H]782.52
C43H75NO8PF
[M-H]762.51
C43H74NO8P
[M-H]780.50
C43H73NO8PF
[M-H]776.52
C44H76NO8P
[M-H]637.41
C32H63O10P
[M-H]665.44
C34H67O10P
[M-H]693.47
C36H71O10P
[M-H]711.46
C36H70O10PF
[M-H]729.45
C36H69O10PF2
[M-H]691.46
C36H69O10P
[M-H]705.47
C37H71O10P
[M-H]721.50
C38H75O10P
[M-H]739.49
C38H74O10PF
[M-H]757.48
C38H73O10PF2
[M-H]719.49
C38H73O10P
[M-H]737.48
C38H72O10PF
[M-H]755.47
C38H71O10PF2
[M-H]717.47
C38H71O10P
[M-H]735.46
C38H70O10PF
[M-H]753.45
C38H69O10PF2
[M-H]733.50
C39H75O10P
[M-H]751.49
C39H74O10PF
[M-H]769.48
C39H73O10PF2
[M-H]731.49
C39H73O10P
[M-H]749.48
C39H72O10PF
[M-H]767.47
C39H71O10PF2
[M-H]747.52
C40H77O10P
[M-H]765.51
C40H76O10PF
[M-H]783.50
C40H75O10PF2
[M-H]761.53
C41H79O10P
[M-H]779.52
C41H78O10PF
[M-H]797.52
C41H77O10PF2
[M-H]759.52
C41H77O10P

Exact
m/z of
the ion
750.51
768.50
748.49
766.48
770.57
788.56
782.51
762.51
780.50
776.52
637.41
665.44
693.47
711.46
729.45
691.46
705.47
721.50
739.49
757.48
719.49
737.48
755.47
717.47
735.46
753.45
733.50
751.49
769.48
731.49
749.48
767.47
747.52
765.51
783.50
761.53
779.52
797.51
759.52

∆MS(ppm)
0.82
2.00
2.09
1.68
0.80
0.81
1.78
1.47
1.97
1.89
1.00
1.26
0.34
0.93
1.07
0.42
0.48
1.58
1.57
0.90
0.95
1.10
0.44
0.61
0.62
0.24
1.41
0.88
0.50
0.39
0.41
2.26
1.72
1.19
0.93
1.10
0.85
1.23
0.77
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Compound
PG(35:2)-1F
PG(35:2)-2F
PG(35:4)-1F
PG(35:5)
PG(36:1)-1F
PG(36:2)
PG(36:2)-1F
PG(36:2)-2F
PG(37:2)
PG(37:2)-1F
PG(37:2)-2F
PG(37:5)
PG(37:5)-1F
PG(38:2)
PA(26:0)
PA(32:0)
PA(32:0)-1F
PA(32:0)-2F
PA(32:1)
PA(32:1)-1F
PA(32:1)-2F
PA(32:2)
PA(33:1)
PA(33:2)
PA(34:1)
PA(34:1)-1F
PA(34:1)-2F
PA(34:2)
PA(34:2)-1F
PA(35:1)
PA(35:1)-1F
PA(35:1)-2F
PA(35:2)
PA(35:2)-1F
PA(36:2)
PA(36:2)-1F
PA(37:2)
PS(32:0)
PS(32:0)-1F

Table S3.2 continued
Detected
Ionized
Formula
m/z of
Species
the ion
[M-H]777.51
C41H76O10PF
[M-H]795.50
C41H75O10PF2
[M-H]773.48
C41H72O10PF
[M-H]753.47
C41H71O10P
[M-H]793.54
C42H80O10PF
[M-H]773.53
C42H79O10P
[M-H]791.52
C42H78O10PF
[M-H]809.51
C42H77O10PF2
[M-H]787.55
C43H81O10P
[M-H]805.54
C43H80O10PF
[M-H]823.53
C43H79O10PF2
[M-H]781.50
C43H75O10P
[M-H]799.49
C43H74O10PF
[M-H]801.56
C44H83O10P
[M-H]563.37
C29H57O8P
[M-H]647.47
C35H69O8P
[M-H]665.46
C35H68O8PF
[M-H]683.45
C35H67O8PF2
[M-H]645.45
C35H67O8P
[M-H]663.44
C35H66O8PF
[M-H]681.43
C35H65O8PF2
[M-H]643.43
C35H65O8P
[M-H]659.47
C36H69O8P
[M-H]657.45
C36H67O8P
[M-H]673.48
C37H71O8P
[M-H]691.47
C37H70O8PF
[M-H]709.46
C37H69O8PF2
[M-H]671.47
C37H69O8P
[M-H]689.46
C37H68O8PF
[M-H]687.50
C38H73O8P
[M-H]705.49
C38H72O8PF
[M-H]723.48
C38H71O8PF2
[M-H]685.48
C38H71O8P
[M-H]703.47
C38H70O8PF
[M-H]699.50
C39H73O8P
[M-H]717.49
C39H72O8PF
[M-H]713.51
C40H75O8P
[M-H]734.50
C38H74NO10P
752.49
C38H73NO10PF [M-H]-

Exact
m/z of
the ion
777.51
795.50
773.48
753.47
793.54
773.53
791.52
809.51
787.55
805.54
823.53
781.50
799.49
801.56
563.37
647.47
665.46
683.45
645.45
663.44
681.43
643.43
659.47
657.45
673.48
691.47
709.46
671.47
689.46
687.50
705.49
723.48
685.48
703.47
699.50
717.49
713.51
734.50
752.49

∆MS(ppm)
0.40
1.67
1.95
1.77
0.26
1.21
0.71
0.35
0.36
0.88
0.64
2.35
1.70
0.30
0.92
1.42
1.11
0.09
0.88
1.04
-1.01
0.80
1.85
1.17
1.14
0.85
-1.39
0.62
0.93
0.46
1.19
-0.19
0.68
0.70
0.74
0.47
0.65
0.94
0.54
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Compound
PS(32:0)-2F
PS(32:1)
PS(34:1)
PS(34:1)-1F
PS(34:1)-2F
PS(34:2)
PC(30:0)
PC(32:0)
PC(32:1)
PC(33:1)
PC(34:1)

Table S3.2 continued
Detected
Ionized
Formula
m/z of
Species
the ion
770.48
C38H72NO10PF2 [M-H][M-H]732.48
C38H72NO10P
[M-H]760.51
C40H76NO10P
[M-H]778.50
C40H75NO10PF
796.49
C40H74NO10PF2 [M-H][M-H]758.50
C40H74NO10P
[M+H]+
706.54
C38H76NO8P
[M+H]+
734.57
C40H80NO8P
[M+H]+
732.55
C40H78NO8P
[M+H]+
746.57
C41H80NO8P
[M+H]+
760.58
C42H82NO8P

Exact
m/z of
the ion
770.48
732.48
760.51
778.50
796.49
758.50
706.54
734.57
732.55
746.57
760.59

∆MS(ppm)
0.82
0.60
0.84
0.85
0.98
0.64
-0.11
0.71
-0.72
-0.91
-0.96
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Table S3. 3. Cell abundances in cultures of strain 273 under different growth conditions
determined when samples for fatty acids and GP analyses were collected.
Substrate

qPCR (cell number/mL culture)

Decanoate
Decane
FD
DFD
Decane+Fluroide
Decane+MFA

(2.7 ± 0.2) × 109
(8.4 ± 0.5) × 108
(9.2 ± 0.8) × 108
(1.1 ± 0.0) × 109
(3.9 ± 1.5) × 108
(8.2 ± 1.0) × 107
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Chapter 4. Genomics and comparative transcriptomics unravel
fluoroalkane metabolism in Pseudomonas sp. strain 273
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4.1 Abstract
Fluorinated chemicals are emerging as recalcitrant contaminants that are less susceptible
to biodegradation, presumably due to the strength of their carbon-fluorine bonds. The pure culture
Pseudomonas sp. strain 273 is capable of growing with fluoroalkanes as substrates under oxic
conditions and releasing nearly stoichiometric amount of fluoride, indicating the presence of
enzyme system(s) responsible for cleaving the carbon-fluorine bonds. Cells of strain 273
assimilated a small part of the fluorine during growth with fluoroalkanes and synthesized
biological macromolecules such as glycerophospholipids with fluorine substituents. We analyzed
the genome of strain 273 and compared the transcriptomes of cells grown with 1,10-difluorodecane
(DFD), decane, and acetate. The combined approaches of genome and comparative transcriptome
analyses pinpointed defluorinating enzyme systems and fluoroalkane metabolism pathway in
strain 273. Three genes encoding alkane 1-monoxygenases (AlkB) were presented in the genome
of strain 273 and one of them (alkB, gene ID 2814128504) was highly expressed in both decaneand DFD-grown cells compared with that in acetate-grown cells, suggesting that this AlkB is likely
responsible for oxidizing both decane and DFD. The defluorination of the one terminal
fluoromethyl group occurred in the oxidation by AlkB in the case of DFD. Adjacent to the alkB, a
gene encoding ferredoxin reductase was co-expressed and played a role as a subunit. One gene
cluster containing a (S)-2-haloacid dehalogenase (had) gene was specifically upregulated in cells
grown with DFD suggesting that this HAD (2814128232) might be involved in defluorination of
fluoro-fatty acid generated during DFD metabolism. Genes involved in fatty acid biosynthesis
pathway were not differentially expressed under three different growth conditions. The enzyme
systems involved in synthesizing long-chain fatty acid may promiscuously incorporate the fluorofatty acids as regular substrates yielding the fluorinated long-chain fatty acid. This transcriptional
evidence for DFD metabolism in strain 273 can advance the understanding of the enzymes
involved in defluorination and assist in forming strategies for the biodegradation, remediation, and
remediation of fluorinated organics.

4.2 Introduction
Fluorinated chemicals have been developed and applied in a variety of medical,
agrochemical, military and industrial applications.1-3 Ubiquitous, fluorinated chemicals have been
detected and persist in many environmental matrices and have emerged as recalcitrant
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contaminants, in particular per- and polyfluoroalkyl substances (PFAS).4, 5 PFAS with multiple
fluorine substitutions are major components of aqueous film-forming foams (AFFFs) used as fire
suppressants and usually commingled with less fluorinated compounds, including fluoroalkanes.6,
7

Over 40 classes of PFAS, including part of incomplete transformation products, have been

detected in groundwater collected from military bases with histories of AFFF application.7 Only a
few fluorinated chemicals can be completely degraded by microorganisms.8-10 Substantially fewer
enzymes with defluorination capability have been determined compared with enzymes that can
break other carbon-halogen bonds.11-13
The strength of the C-F bond is the major hindrance to transforming fluorinated organic
compounds. The Van der Waals radii of the halogen atoms decrease in the order of I > Br > Cl >
F, whereas the electronegativity follows the opposite order, with fluorine being the most
electronegative element in the periodic table. These properties confer a strong polarity to the C-F
bond, and the C-halogen bond strength increases in the order of I < Br < Cl < F.14, 15 The strength
and unique properties of the C-F bond make it less susceptible to biodegradation. Most of the
haloalkane-degrading bacteria reported so far are restricted to dehalogenate chloro-, bromo- and
iodo-alkanes, but not fluoroalkanes. For example, Pseudomonas sp. strain ES-2 can utilize
medium-chain 1-bromoalkanes and 1-chloroalkanes as carbon sources but cannot grow with or
defluorinate 1-fluorononane and 1-fluorohexane.16 Arthrobacter sp. strain HA1 is able to utilize
18 different C2 to C6 1-chloro-, 1-bromo-, and 1-iodoalkanes as sole carbon and energy sources
but is incapable of degrading 1-fluoropentane.17 These observations demonstrate that enzyme
systems capable of dehalogenating chloro-, bromo- and iodo-organics may not be compatible with
the fluorinated analogs. Crystal structure analysis of fluoroacetate dehalogenase has demonstrated
the selectivity to fluorinated substrate derived from the halide binding pocket, which supplies three
hydrogen bonds to stabilize the fluoride and is tailored to the sterically smaller fluorine atom.18
Although the C-F bond is more difficult to break than other carbon-halogen bonds, multiple
microbiology studies have proved that natural enzyme systems can break the C-F bond through
oxygenolytic,19 hydrolytic,20 reductive11 and hydration mechanism12 at neutral pH and at room
temperature. A collection of studies has demonstrated that microorganisms can utilize the
fluorinated organics as a source for growth with concomitant defluorination.21-23
Pseudomonas sp. strain 273 is able to utilize 1-fluoroalkane (C7 to C10, and C14) and 1,10difluoroalkane (DFD) as the sole carbon source for growth.23 During growth with fluoroalkane,

100

nearly stoichiometric amount of fluorine was recovered as inorganic fluoride in the extracellular
matrix. Physiological test has determined that growth of strain 273 with fluoroalkane is oxygendependent while the enzyme responsible for defluorination remains elusive. Metabolomics and
lipidomics identified fluorinated long-chain fatty acid and fluorinated glycerophospholipid in
fluoroalkane-grown cells of strain 273. In this study, we applied genomic and comparative
transcriptomic approaches to investigate the defluorination enzyme system(s) and the fluoroalkane
metabolism pathway in strain 273.

4.3 Materials and Methods
Chemicals.
1,10-difluorodecane (DFD) (> 97%) was custom-synthesized (Carbosynth, Newbury, UK).
Sodium acetate, chloroform (> 99.8%) and sodium fluoride was obtained from Sigma-Aldrich (St.
Louis, MO, USA). n-Decane (decane) was obtained from Acros Organics (Fair Lawn, NJ, USA).
Ethanol (> 99.5%) and TRIzol reagent was purchased from Thermo Fisher Scientific (Waltham,
MA, USA). All other chemicals used were analytical reagent grade or higher, unless otherwise
specified.

Cultivation of Pseudomonas sp. strain 273.
Pseudomonas sp. strain 273 is a soil isolate that can utilize decane, fluoroalkanes and
acetate as the sole carbon source.23, 24 Cultures of strain 273 were grown with the defined mineral
salt medium buffered with phosphate around pH 7.3 as described.23 The culture was grown in the
160-mL serum bottle containing 50 mL of medium and 110 mL of air headspace and closed with
black butyl rubber stopper held in place with aluminum crimps (Bellco Glass Inc., Vineland, NJ,
USA). The culture was routinely maintained with the transfer on different carbon substrates,
including acetate, decane and DFD, respectively. The substrate adapted cells were obtained by
transferring more than five times on the specific carbon substrate (i.e., acetate, decane and DFD,
respectively) and were supplied as the inoculum for the comparative transcriptomic study. The
culture set for transcriptomic study received acetate (25 mM), decane (5 mM, nominal) and DFD
(5 mM, nominal), respectively, as the sole carbon source and the 160-mL serum bottle was covered
with aluminum foil to allow gas exchange in headspace. All bottles were shaken at 120 rpm in an
upright position and incubated at 30°C. The time series growth curves of cultures with different
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substrates were established under the same growth condition by measuring the optical density
(OD600nm) of 1 mL suspension at each time point. The sampling time for mid-exponential phase
cells according to different substrates was determined by the corresponding growth curve and
verified by the OD600nm measurement just before the sample collection.

DNA extraction, genome sequencing and annotation.
The genomic DNA of strain 273 was extracted from 1.5 mL of culture following the
established protocol using hexadecyltrimethylammonium bromide method.25 The whole genome
sequencing of strain 273 was completed using PacBio RS II platform (Pacific Bioscience, Menlo
Park, CA, USA) and the genome assembling resulted in one circular chromosome with 107.6
coverage by the Genomics Core at University of Maryland. The strain 273 genome has been
submitted to JGI IMG/M-ER database with the IMG genome ID 2814122901 and IMG annotation
pipeline (v.5.0.0) was applied to predict protein coding sequences and annotate gene function.26
The gene function annotation was primarily determined by the annotation of protein-coding genes
based on multiple protein databases, including KEGG Orthology Terms (v.77.1), COG, Pfam (v.30)
and TIGRFAMs (v.15.0) using IMG annotation pipeline. The annotation accuracy of the interested
genes was verified by the manually blast genes against the NCBI (https://www.ncbi.nlm.nih.gov/)
and Uniprot (https://www.uniprot.org/) databases returning the consensus annotation. The
calculation of the whole-genome amino acid identity (AAI) of strain 273 to other species was
conducted by Microbial Genomes Atlas (MiGA) webserver.27

RNA extraction, transcriptome sequencing and analysis.
This study applied TRIzol reagent and chloroform to lyse the cells for RNA extraction.28
The experimental effort determined the balance between the volume of lysing solvent and the
amount of cells for extraction that was crucial to RNA quality and yields. The cell pellet was
collected from 5 to 10 mL of culture suspension, containing 3.4 × 109 to 1×1010 cells in total, by
centrifuging for 15 mins at 10,000 × g at room temperature and stored at -80°C immediately. The
cell pellet was later resuspended in 5 mL of TRIzol and incubated at room temperature for 5 mins
in the polypropylene conical tube (Corning Inc.). 1 mL of chloroform was then added to lyse the
cell and mix the suspension by inverting the falcon tube upside down three times without extensive
perturbation. The sample was incubated for 3 minutes and then centrifuged for 15 mins at 12,000
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× g at 4°C (Thermo Fisher Scientific Sorvall RC 6 plus). 2.4 mL of colorless upper aqueous layer
were transferred to a fresh polypropylene conical tube (Corning Inc.) and mixed with the same
volume of 75% ethanol (v:v). The mixture was then purified using the column-based RNeasy Mini
Kit (Qiagen, Hilden, Germany) with the combination of the RNase-Free DNase Set (Qiagen,
Hilden, Germany) to eliminate genomic DNA, following the manufacture’s protocol. The RNA
was quantified by Nanodrop 2000 spectrophotometer (Thermo Fisher Scientific). The
concentration and quality of the RNA represented by RNA integrity number (RIN) were verified
by RNA electrophoresis using an RNA 6000 Nanochip (Agilent, Santa Clara, CA, USA) on an
Agilent 2100 Bioanalyzer. The raw RNA extraction in all samples had RIN higher than 8.4
(besides abnormal 16S rRNA peaks determined in DFD-grown cells) indicating that only moderate
degradation of RNA occurred during the extraction procedures.
The rRNA was depleted prior to sequencing and the triplicate RNA extractions from three
different growth conditions were sequenced by NovaSeq platform (Illumina, San Diego, CA, USA)
at the Genomics Core at University of Maryland. The transcript library was generated with the size
of 27 to 36 million raw reads for each sample. The transcriptome data were mapped to strain 273
genome and compared the expression difference according to the following workflow on KBase
pipeline (https://www.kbase.us/). All sequences past the FastQC (v 0.11.5) quality check averaged
a Phred quality score as 36. The sequences were trimmed using the Trimmomatic (v 0.36) at its
default setting, preserving 97% of the total sequences.29 The trimmed sequences were aligned to
the closed strain 273 genome as a reference using the both HISAT2 (v 2.1.0)30 and Bowtie2 (v
2.3.2)31 at default setting. The aligned RNA sequencing reads were assembled using StringTie
(v1.3.3b) and the expression level of each gene was normalized to sample size and gene length
represented by fragments per kilobase of transcripts per million mapped reads (FPKM) and
transcripts per kilobase million (TPM).32 The differentially expressed genes among the growth
conditions were determined using DESeq2 (v1.20.0) with the fold change higher than 2 and the
cutoff p value as 0.01.33, 34

Quantitative reverse transcription polymerase chain reaction (qRT-PCR).
The quantitative reverse transcription polymerase chain reaction (qRT-PCR) assay was
applied to quantify the gene transcript copy number per nanogram of RNA extracted. The RNA
templates for all RNA extractions were diluted to around 2 ng/µL prior to the qRT-PCR assay,
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which was performed using a Power SYBR Green RNA-to CT 1-Step Kit (Applied Biosystems,
Waltham, MA, USA) on a ViiA 7 Real Time PCR system (Applied Biosystems). Primers
specifically amplifying the unique region on alkane 1-monooxygenase (AlkB) encoding genes
(2814127390, 2814128504), respectively, were designed using Geneious Prime (v.11.0.6) with the
criteria of primer melting temperature (Tm) of 57–61°C and the G+C content of the primer ranging
between 50-75 mol % (Appendix, Table S4.1). The specificity of the primer was verified by using
BLAST search against strain 273 genome returning the unique binding region. The oligonucleotide
sequence carrying the amplifying region and primer binding region for two alkB genes was
synthesized individually (Integrated DNA Technologies, Coralville, IA, USA) (Table S4.1). The
qRT-PCR cycle conditions were set as follows: 48°C for 30 min and then held at 95°C for 10 min,
followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. The melt curve step, including 95°C
for 15 s, 60°C for 15 s and 95°C for 15 s, was included in the end of the assay. The eight-point
standard curve (R2 > 0.996) for targeted gene was established by serial dilution of the synthetic
oligonucleotide in three technological replicates. The amplification efficiency of the alkB genes
was 96.0% and 103.4%, respectively, and the specific amplification was indicated by observing
the single peak on the melt curve plot. The extremely low signal obtained from the negative control
which did not receive the reverse transcriptase (included in kit) indicated that the genomic DNA
was substantially removed during the RNA extraction.

Phylogenetic analysis.
Thirty-one amino acid sequences encoding AlkB homologous protein from fourteen
alkane-degrading bacteria and two taxonomically closely related Pseudomonas spp. were retrieved
from JGI IMG and Uniprot database (Table S4.2). Twenty-two amino acid sequences of (S)-2haloacid dehalogenase (had), haloalkane dehalogenase (hkd) and fluoroacetate dehalogenase (facd)
with experimentally verified dehalogenation activity were collected from the Uniprot database
(Table S4.3). The phylogenetic trees of indicated genes were constructed using an unweighted pair
group method with arithmetic mean (UPGMA) with the Jukes-Cantor model in Geneious Prime
(v.11.0.6).35
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Analytical procedures.
The fluoride released was quantified using an ICS-2100 (Dionex, Sunnyvale, CA, US) ion
chromatography system equipped with a 4 mm  250 mm IonPac AS18 hydroxide-selective anionexchange column and a conductivity detector. The mobile phase was isogradient 20 mM potassium
hydroxide at a flow rate of 1 mL min-1. The optical density of cultures was determined by briefly
vortexing 1 mL of culture suspension and the absorbance was read at 600 nm using a 20D+
spectrophotometer (Thermo Fisher Scientific).

4.4 Results
Genome analysis of strain 273.
The genome of strain 273 compromises one 7,477,410 bp circular chromosome with G+C
content of 67.5%. The genome contains 6890 genes, including 6758 protein coding genes and five
16S rRNA genes. 16S rRNA-based RDP classification determined that strain 273 is within the
genus of Pseudomonas.36 The whole-genome based AAI analysis by MiGA determined that the
most closely related species is Pseudomonas citronellolis which has a AAI value of 94.07% with
strain 273.37 Three alkB (2814127390, 2814127750 and 2814128504) were presented in the
genome of strain 273, which enables strain 273 to initiate alkane oxidation. The genome encodes
a complete tricarboxylic acid (TCA) cycle, allowing strain 273 to completely oxidize acetyl-CoA
to CO2 and generate reducing equivalents (i.e., NADH and NADPH). Strain 273 is a facultative
aerobe that is also able to grow with nitrate, nitrite, or nitrous oxide as the electron acceptor under
anoxic condition. Strain 273 possesses a complete denitrification pathway, including nitrate
reductase (2814126011 to 2814126014 and 2814126954 to 2814126957), nitrite reductase
(2814131400), nitric oxide reductase (2814128246, 2814131407, and 2814131408) and nitrous
oxide reductase (2914131414). Strain 273 can utilize sulfate as the sulfur source for growth, and
the genome has eight copies of alkanesulfonate monooxygenase genes (2814125508, 2814125510,
2814127183, 2814127184, 2814127852, 2814128412, 2814129305, 2814131340) suggesting
strain 273 may utilize alkanesulfonate as the sulfur source.

Transcriptional response to different carbon substrates in strain 273.
The cells were collected during the mid-exponential phase at 24 h for acetate, 48 h for
decane, and 48 h for DFD, respectively, after inoculation (Appendix, Figure S4.1). The transcript
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library with 26 to 35 million pair-end raw reads resulted in a high coverage 70 to 94 of the strain
273 genome. The purity of the culture was verified by over 99% of the sequence reads in all
samples being able to be mapped to strain 273 genome after the alignment using either HISAT2
(v2.1.0) or Bowtie2 (v2.3.2). The two independent alignment methods using the same assembling
set yielded similar results of the FPKM values (Figure S4.2). The following gene expression results
described were derived from the alignment using Bowtie2. The gene expression level was
represented by the FPKM value and 98% of the genes in strain 273’s genome were detected with
transcripts (FPKM > 0) (Table 4.1). The expression profile of strain 273 indicated that 23% of the
genes were expressed with FPKM values higher than 100, and 2% of genes were expressed with
FPKM values above 1000. A similar gene expression profile was found in another study with
comparable coverage number (100).38 To minimize the annotation ambiguity and focus on the
significantly expressed genes, the genes with FPKM values over 100 under all three growth
conditions were selected as the highly expressed genes for expression comparison 39, 40.
Principal component analysis (PCA) of 6755 expressed genes revealed the apparent
separation among transcriptomes of cells grown with acetate, decane, and DFD, respectively,
which suggested different transcriptional responses to different carbon substrates (Figure 4.1 A).
Among 1553 highly expressed genes (HEG) (FPKM >100), 494 of them were highly expressed
under all three growth conditions (Figure 4.1 B). 380 HEG were exclusively found in cells grown
with acetate, revealing their lower expression during growth with other two substrates. The number
of HEG exclusively determined in decane-grown cells was relatively low at 65. During growth
with DFD, 928 HEG were determined while 247 of them exclusively showed high transcription to
DFD. The pairwise comparison of the differentially expressed genes in response to carbon
substrates is demonstrated as volcano plots (Figure 4.1 C,D,E). In the comparison between the
cells grown with DFD and acetate, 549 genes were upregulated in cells grown with DFD while
533 genes were stably expressed (Figure 4.1 C). Compared to cells grown with decane, 799 genes
were upregulated in response to DFD as the carbon source with the fold change number up to 5955
(Figure 4.1 D). Over a thousand genes were upregulated in cells grown with decane compared to
those grown with acetate, and the maximum fold change of gene expression increase was 239
(Figure 4.1 E).
In the total of 1553 HEG, 1170 genes have predicted functions according to the Clusters
of Orthologous Groups (COG) functional category.41 In all functional categories, more than half
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of the HEG were related to the translation, ribosomal structure and biogenesis; transcription; signal
transduction mechanisms; lipid transport and metabolism; energy production and conversion and
amino acid transport and metabolism (Figure 4.2). In cells grown with decane, more HEG (39)
were involved in cell motility than the numbers in acetate (28) and DFD (31). When DFD was
supplied as the carbon source, more HEG (86) with the predicted function in lipid transport and
metabolism and energy production and conversion were determined than under other growth
conditions.

The uptake of water-insoluble substrate by strain 273.
To access the water-insoluble substrate, microorganisms utilize different strategies,
including producing biosurfactant to emulsify the substrate and/or forming biofilm to enhance the
contacts between cells and substrates.42 Unlike P. aeruginosa DQ843 and P. aeruginosa SJTD-1,
which produce rhamnolipids as biosurfactants to emulsify the immiscible alkane, strain 273 does
not possess the rhlA and rhlB genes which are involved in rhamnolipids production.44 Strain 273
encodes the complete pathway for alginate production, but not for Pel or Psl, which are important
polysaccharides secreted by Pseudomonas spp. as the biofilm matrix.45 At the mid-exponential
phase, the genes involved in chemotaxis sensing and regulating including the methyl-accepting
chemotaxis protein (MCP) (2814129408) and purine-binding chemotaxis protein (CheW)
(2814129857) were upregulated in cells grown with (fluoro)alkane. Meanwhile, the expression of
genes associated with flagellar components synthesis including fliEF (2814130008, 2814130009),
flgFGH (2814130033 to 2814130035) and flhA (2814129869) were all upregulated in cells grown
with (fluoro)alkane and showed higher expression with decane than with DFD. However, the
expression levels of genes involved in biofilm formation, such as alginate production [e.g., algE
(2814125983), alg8 (2814122901)], were not highly expressed under all growth conditions. The
substantial cell aggregate around the hydrocarbon drop was only observed during the stationary
phase when decane or DFD was supplied as the carbon source.

Differential expression of alkB during growth with different carbon substrates.
There are three alkB genes (2814127390, 2814128504, 2814127750) in strain 273 genome,
and they share 25 to 31% amino acid sequence identity. The phylogenetic analysis of three alkB
genes in strain 273 and 31 homologous genes collected from sixteen alkane-degrading bacteria or
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taxonomically closely related species demonstrated the high sequence variation at inter-species
level (15% to 99%) (Figure S4.3). Two alkB genes (2814127390, 2814127750) in strain 273
genome were not highly expressed (FPKM < 33) under all growth conditions (Figure 4.3 A).
However, the other alkB (2814128504) was upregulated in cells grown with decane (FPKM = 644)
and DFD (FPKM = 1505), which was remarkably higher compared to the gene expression level in
acetate-grown cells (FPKM = 3) (Figure 4.3 B). The expression levels of alkB (2814127390) and
alkB (2814128504) under different growth conditions were also examined with qRT-PCR (Figure
4.3 C). The up-regulation of alkB (2814128504) on (fluoro)alkane verified that 6,581 ± 865,
13,585 ± 1,595, and 171 ± 10 copies/ng RNA were determined in cells grown with decane, DFD,
and acetate, respectively (Figure 4.3 C). These results corroborate the RNA sequencing results
indicated by the FPKM values (Figure 4.3 B). The low expression level of alkB (2814127390)
under any growth conditions was also verified with qRT-PCR (< 700 copies/ng RNA) (Figure 4.3
C).
In the gene cluster containing alkB (2814128504), the co-expression of a neighbor gene
was observed that the ferredoxin reductase (fer2) (2814128505) was conjointly upregulated in cells
grown with decane (FPKM = 1317) and DFD (FPKM = 1846) compared to acetate (FPKM = 9).
The upstream gene (2814128503) encoding the outer membrane porin D (oprD) was also
upregulated under (fluoro)alkane-growing condition as well. The genes on a cluster adjacent to
alkB (2814127390) or alkB (2814127750) were not highly expressed (FPKM < 135).

Fatty acid metabolism in strain 273.
The oxidation of alkanes will generate fatty acids, which are catabolized through the βoxidation pathway. In each iterative cycle of β-oxidation, the fatty acyl-CoA will be shortened by
two carbon atoms and generates one acetyl-CoA molecule. Compared to acetate-grown cells,
genes involved in β-oxidation, including acyl-CoA dehydrogenase (acd) (2814127786), enoylCoA hydratase (echA) (2814125951), 3-hydroxyacyl-CoA dehydrogenase (fadJ) (2814129298)
and acetyl-CoA acyltransferase (fadA) (2814129313) were upregulated more than two-fold when
decane and DFD were supplied as the growth substrate (Figure 4.4). The substrate DFD
significantly induced the expression of fadA (2814129764) and fadB (2814129765) in strain 273,
but decane did not. For acetyl-CoA acetyltransferase (atoB), there are twelve gene homologs
presented in strain 273 genome. Three gene homologs including atoB (2814125659) (FPKM =
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297), atoB (2814128662) (FPKM = 849), and atoB (2814128669) (FPKM = 722) were only highly
expressed in cells grown with DFD, which stayed at a low expression level under the other two
growth conditions (FPKM < 54). In cells grown with decane, the homolog atoB (2814129299) was
upregulated (FPKM = 703), and was relatively less expressed in cells grown with DFD (FPKM =
124).
To synthesize long-chain fatty acids for constructing cellular structure, such as the
glycerophospholipid in cellular membrane, the iterative cycle of fatty acid synthesis can elongate
the fatty acyl chain in two carbon atoms by condensing a malonyl-ACP and an acyl-ACP molecule,
initially to an acetyl-ACP. In contrast to genes involved in β-oxidation, the genes associated with
the fatty acid synthesis, including the 3-oxoacyl-ACP synthase (fabB) (2814127534), 3-oxoacylACP reductase (fabG) (2814129713), 3-hydroxyacyl-ACP dehydratase (fabA) (2814127535) and
enoyl-ACP reductase (fabV) (2814129693), were not differentially expressed in response to
different carbon substrates, which showed a fold change number less than two between any
pairwise comparison.

(S)-2-haloacid dehalogenase catalyze the defluorination of fluorofatty acids.
The genome of strain 273 contains two (S)-2-haloacid dehalogenase (had) genes. One had
(2814127154) was not highly expressed under any growth conditions (FPKM < 5). The had
(2814128232) was highly expressed (FPKM = 271) in cells grown with DFD which is three times
and seven times higher than that in decane and acetate, respectively (Figure 4.5). On the gene
cluster containing had (2814128232), two genes (2814128229, 2814128230) encoding calciumdependent chloride channel (Ca-ClC) proteins (yfbK) which serve as the anion channel, one gene
(2814128226) encoding MoxR-like ATPase (moxR) and one gene (2814128225) encoding fatty
acid transport protein (fadL) were identified. In response to DFD, genes encoding Ca-ClC proteins
and MoxR-like ATPase were all upregulated.

4.5 Discussion
Defluorination enzyme systems in strain 273.
Alkane 1-monooxygenase (AlkB) and cytochrome P450 alkane hydroxylase (P450) are
two major enzyme systems initiating alkane oxidation and most alkane-degrading P450 belong to
the CYP153 subfamily.46-48 Five genes encoding P450 (2814125567, 2814127004, 2814127041,
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2814127155, 2814127435) were annotated in strain 273genome and none of them were classified
to the CYP153 subfamily based on amino acid sequence similarity. All five P450-encoding genes
were expressed at low levels (FPKM < 36) under three growth conditions, indicating that the
degradation of decane and DFD in strain 273 were not associated with P450 activity. The
possibility of DFD defluorination by a haloalkane dehalogenase (hkd) (2814131473) in strain 273
was excluded since this hkd gene was transcribed in a low level under all growth conditions (FPKM
< 36). There are three different alkB genes annotated in strain 273 genome, while the same alkB
(2814128504) was highly expressed in cells grown with decane and DFD, respectively. Previous
study showed that decane-grown cells immediately degraded DFD without any lag phase.23 These
observations indicate that the same enzyme AlkB (2814128504) initiates both decane and DFD
catabolism in strain 273, which results in the defluorination of one of the terminal fluoromethyl
group in DFD.
To initiate DFD catabolism, AlkB oxidizes the terminal fluoromethyl group of DFD in
generating the germinal-fluorohydrin, followed by the spontaneous intracellular elimination with
concomitant fluoride release. The dehalogenation catalyzed by monooxygenase has been reported
in halogenated aromatics and aliphatics, primarily focused on the chlorinated chemicals.49, 50 In
vitro, the soluble methane monooxygenase in Methylosinus trichosporium OB3b could degrade
dichlorofluoromethane and release chloride and fluoride.51 The phylogenetic analysis of alkB
determined a high amino acid sequence variation, which can be explained by the broad substrate
range of AlkB including alkanes with different length and alkanes with or without halogen
substitution.52-54 The alkB (2814128504) in strain 273 is a homolog to alkB (A0A2V2SWG1) in
Pseudomonas sp. RW407, which shared an amino acid identity of 99.2% (Figure S4.3). Strain
RW407 was isolated from the sediment of the River Elbe, polluted by diclofenac, which is a
nonsteroidal anti-inflammatory drug possessing two carbon-chlorine bonds. Growth test proved
that strain RW407 could utilize diclofenac as the sole carbon source for growth; however, the
dehalogenating capability was not reported.55 Strain 273 and strain RW407 sharing highly similar
alkB genes were both isolated from the environment polluted by the halogenated chemicals and
both strains proved to utilize the halogenated chemicals as the sole carbon source for growth. 24
This observation indicates that natural enzyme systems in microorganisms can evolve to break the
carbon-halogen bonds in anthropogenic pollutants. Unlike the majority of the AlkB proteins
requiring electron transfer protein rubredoxin and rubredoxin reductase as the subunits to
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hydroxylate the alkane,56 the alkB (2814128504) is adjacent to a ferredoxin reductase encoding
gene in strain 273 genome which shows a similar transcriptional pattern. Cooperation of AlkB
with ferreodoxin reductase in oxidizing medium-chain alkane was also discovered in
Thalassolituus oleivorans MIL-1 in a proteomic study.57
Half the amount of the fluorine in DFD was released by AlkB oxidation, and the
transformation products (i.e., ω-fluoro-aldehyde, ω-fluoro-fatty acid) were channeled in to the βoxidation pathway. Previous work had detected ω-fluoro-fatty acids such as fluoro-hexanoic acid
as the degradation intermediates of DFD in strain 273. The co-metabolic defluorination on
monofluoroacetate (MFA) was observed in strain 273, indicating that the enzyme system is
capable of defluorinating MFA presented in strain 273. The gene encoding the fluoroacetate
dehalogenase (Facd), which belongs to the alpha/beta hydrolase superfamily, was not found in
strain 273 genome.18 While a had (2814128232) was annotated as the gene encoding HAD which
belongs to the haloacid dehalogenase-like hydrolase superfamily. The genes encoding the HAD
(2814128232), fatty acid transporter protein and anion channel protein on the same cluster were
all significantly upregulated in cells grown with DFD, indicating the had (2814128232) may
involve in the defluorination of MFA. The HAD catalyze dehalogenation to fluoroacetate and
chloroacetate were both demonstrated.58, 59 The high amino acid sequence similarity prohibited
differentiating the defluorinating HAD from the non-defluorinating HAD based on sequence
analysis (Figure S4.4).59 The genes encoding fatty acid transport protein (FadL) (2814128225) and
anion channel (YfbK) (2814128229 and 2814128230) which fluoride can permeate through were
co-expressed with the had (2814128232) suggesting a cooperating process including transport the
ω-fluoroacid into the functional cellular compartment followed by the defluorination and
transporting the released fluoride outside the cell.60
In strain 273, two enzyme systems containing AlkB (2814128504) and HAD (2814128232),
respectively are speculated to defluorinate the DFD. The two enzyme systems work synergistically
to release close to stoichiometric amount of fluorine from fluoroalkanes as inorganic fluoride.

The metabolism of DFD in strain 273.
In response to water immiscible substrates (i.e., decane and DFD), the genes associated
with chemotaxis sensing (cheWY) and flagellar assembly synthesis (fliDEFGH, flgGHI and flhA)
were upregulated (Figure 4.6). The enhanced production of flagellum improved cell motility which
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can drive cell close to the insoluble hydrocarbon drops and increase the contact to substrate surface.
The higher expression of genes associated with flagellar assembly in cells grown with decane than
that with DFD, can be explained by the lower solubility of decane than DFD. Moreover,
microorganisms may generate biosurfactant such as rhamnolipid and polysaccharides to emulsify
the immiscible substrates and enhance the substrate accessibility.45, 61 Strain 273 genome encodes
the complete pathway in producing a polysaccharide, alginate, while all genes stayed lowexpressed under all three growth conditions. These transcriptional observations indicate that at the
mid-exponential phase, the uptake of water insoluble substrate (i.e., decane and DFD) relied on
the direct contact between the substrate surface and highly motile cells without significant
biosurfactant production.62, 63 The improved cell motility and limited polysaccharide production
was corroborated with the observation that biofilm was not significantly formed at the midexponential phase.64
The OprD family proteins served as the channel to uptake a variety of nutrients including
vanillate, histidine and aconitate in Pseudomonas aeruginosa.65 The oprD (2814128503) encoding
the outer membrane OprD family porin adjacent to the alkB (2814128504) may serve as a channel
to transport the DFD into the cytoplasm followed by the oxidation by AlkB and Fer2 (Figure 4.6).
The ω-fluoro-decanoic acid would be generated after the terminal oxidation by AlkB, alcohol
dehydrogenase and aldehyde dehydrogenase. The ω-fluoro-decanoic acid would be channeled into
catabolic β-oxidation pathway supported by the upregulation of associated genes (fadAB, echA and
atoB). The end product of β-oxidation would be MFA-CoA, and one molecule of acetyl-CoA
would be generated in each iterative β-oxidation cycle. Part of the acetyl-CoA can be metabolized
through the TCA cycle generating NADH as the reducing equivalent. Strain 273 is an aerobe with
a complete electron transfer chain of oxidative phosphorylation pathway which can generate
energy (i.e., ATP) through chemiosmosis. Another part of the acetyl-CoA can be transformed to
malonyl-ACP to participate in anabolism such as the long-chain fatty acid synthesis. The longchain fatty acids with one fluorine substitution were detected in cells of strain 273 grown with
DFD in the previous study. Besides the majority of the MFA was defluorinated by the HAD
(2814128232), a meager portion of MFA could be incorporated into the macromolecules through
anabolism. The genes associated with fatty acid synthesis including fabABGVX were not
differentially expressed in response to acetate, decane and DFD indicating this enzyme system
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promiscuously incorporated the MFA as regular substrate (i.e. acetate) and resulted in fluorinated
long-chain fatty acid generation.
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Appendix

Figure 4. 1. (A) Principal component analysis (PCA) of all expressed genes (FPKM > 0) and (B)
Venn diagram showing the distribution of highly expressed genes (HEG) (FPKM > 100) in cells
of strain 273 grown with acetate, decane, and DFD, respectively. (C),(D),(E)Volcano plots
demonstrating the pairwise comparison of HEG expression between carbon substrates. The
expression fold change was determined by the FPKM values between the indicated carbon
substrates, and the significantly upregulated and down-regulated genes were determined by the
log2 (Fold Change) > 1 and log2 (Fold Change) < -1, respectively (p < 0.01). Otherwise, the gene
can be considered as stably expressed. The FPKM value of each gene represents the average of
triplicates.
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Figure 4. 2. Based on COG annotation, the distribution of highly expressed gene (HEG) on
predicted functional category in response to different carbon substrates including acetate, decane
and DFD.
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Figure 4. 3. Transcription level of three alkane 1-monooxygenase (alkB) genes in strain 273 cells
grown with different carbon substrates. (A) The expression of three gene clusters containing alkB.
The heatmap represents the FPKM values of each gene under different growth conditions. The
gene function names are determined with the JGI IMG annotation system, with priority given to
KEGG and TIGRFAM classification. The comparison of alkB (2814127390) and alkB
(2814128504) expression levels under different growth conditions according to (B) FPKM value
and (C) RNA copy number/ng RNA. The data represent the averages of triplicates and error bars
represent standard deviations.
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Figure 4. 4. The expression of genes associated with fatty acid metabolism in strain 273 cells
grown with different carbon substrates. All genes associated with fatty acid metabolism in strain
273 genome were collected from the KEGG fatty acid metabolism pathway (map01212), including
both catabolism as β-oxidation and anabolism as fatty acid synthesis. The iterative cycles of acyl
chain contraction by β-oxidation and extension by fatty acid synthesis with the transformation
intermediates were demonstrated. The carriers would be coenzyme A (CoA) and acyl-carrier
protein (ACP) corresponding to β-oxidation and fatty acid synthesis, respectively. The R group
represented the (fluoro)aliphatic carbon chain. The heatmap represents the averaged FPKM values
of triplicates.
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Figure 4. 5. The gene expression of a gene cluster containing (S)-2-haloacid dehalogenase (had)
(2814128232). The gene function names were determined with the JGI IMG annotation system,
with priority given to KEGG, TIGRFAM, and COG classification. The heatmap represents the
averaged FPKM values of triplicates.
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Figure S4. 2. The comparison of FPKM values determined by two different alignment methods
as HISAT2 and Bowtie2. Alignment output from both methods were assembled with StringTie
using the same setting. Each dot represents the FPKM values of one gene in strain 273 genome
determined by two alignment methods. The data were collected from one of replicates that grown
with DFD.
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Tree scale: 0.2

Figure S4. 3. Amino acid sequence based phylogenetic tree of alkB genes collected from strain
273 and sixteen alkane degrading bacteria or taxonomically closely related species. The alkB genes
in strain 273 are shown in blue font and the one with increased expression in response to
(fluoro)alkane is highlighted with a red pentagram. The tree scale indicates the number amino acid
substitutions per site.
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Figure S4. 4. Amino acid sequence based phylogenetic tree of had, facd and hkd genes. The had
gene in strain 273 is shown in red font. Besides the had in strain 273, all the other genes were
biochemically characterized with dehalogenation activity. The enzymes demonstrated
defluorination activity toward fluoroacetate are in blue font. The enzymes capable of
dechlorinating chloroacetate and chloroalkanes are in black font. The tree scale indicates the
number amino acid substitutions per site.
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Table 4. 1. The gene expression profile in strain 273 at different FPKM cutoff values.

FPKM criteria

Number of genes selected
according to FPKM criteria

Percentage of selected gene to
total genes in strain 273

>0
>1
> 10
> 100
> 200
> 500
> 1000

6755
6647
5103
1553
816
355
165

98%
96%
74%
23%
12%
5%
2%
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Table S4. 1. The primer and oligonucleotide information for genes analyzed by qRT-PCR.
Targeted
Gene

Primer
Name

Primer
Melting
Temperature
(°C)

200qF

60.7

alkB
(2814127390)

alkB
(2814128504)

261qR

58.4

1qF

57.1

66qR

60.3

Primer Sequence (5' to 3')
ATGTGGGAATACATC
AAGTACTACTTCGCA
CCTC
TCAACCATGCGCCAA
CTTAGGTTCGTCAGG
AC
AGGCGAATATTCCGG
GAGTGTTCTCTTTCA
ATGACGCCCAAGGTG
CTGGCCTGGGACCGC

Standard
Efficiency
Curve
(%)
Linearity

R2 =
0.996

103.4%

R2 =
0.999

96.0%
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Table S4. 2. The amino acid sequences of alkB homologous genes presented in alkane degrading
bacteria and taxonomic closely related species.

alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB

Sequence ID
(JGI IMG ID or
Uniprot ID)
638080824
638078188
2521959307
2521963006
2521958693
2792574787
2792573790
2792575239
2884408163
2884407867
2511658591
2776542307

alkB

2512616955

alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB
alkB

637028516
2546104946
2546105847
2546108845
2546101677
2546102758
2688822856
2688823651
2814128504
2814127750
2814127390
643777317
643782083
643778737
643778982
638089119
2550612519
2550612265
2888545122
A0A2V2SWG1
A0A2V2T5D1

Gene
Name

Host

Reference (DOI)

Alcanivorax borkumensis SK2
Alcanivorax borkumensis SK2
Alcanivorax dieselolei B5
Alcanivorax dieselolei B5
Alcanivorax dieselolei B5
Alcanivorax sp. 97CO-6
Alcanivorax sp. 97CO-6
Alcanivorax sp. 97CO-6
Dietzia sp. DQ12-45-1b
Dietzia sp. DQ12-45-1b
gamma proteobacterium sp. HdN1
Gordonia sp. 1D
Leisingera methylohalidivorans
MB2, DSM 14336
Mycobacterium tuberculosis H37Rv
Pseudomonas aeruginosa DQ8
Pseudomonas aeruginosa DQ8
Pseudomonas aeruginosa DQ8
Pseudomonas aeruginosa SJTD-1
Pseudomonas aeruginosa SJTD-1
Pseudomonas citronellolis P3B5
Pseudomonas citronellolis P3B5
Pseudomonas sp. 273
Pseudomonas sp. 273
Pseudomonas sp. 273
Rhodococcus erythropolis PR4
Rhodococcus erythropolis PR4
Rhodococcus erythropolis PR4
Rhodococcus erythropolis PR4
Rhodococcus jostii RHA1
Rhodococcus sp. P14
Rhodococcus sp. P14
Rhodococcus sp. WAY2
Pseudomonas sp. RW407
Pseudomonas sp. RW407

10.1038/nbt1232
10.1038/nbt1232
10.1111/j.1462-2920.2010.02416.x
10.1111/j.1462-2920.2010.02416.x
10.1111/j.1462-2920.2010.02416.x
10.1128/genomeA.00087-18
10.1128/genomeA.00087-18
10.1128/genomeA.00087-18
10.1016/j.biortech.2011.06.009
10.1016/j.biortech.2011.06.009
10.1111/j.1758-2229.2010.00198.x
10.1007/s12223-018-0623-2
10.1099/00207713-52-3-851
10.1128/AEM.66.1.219-222.2000
10.1128/JB.01499-12
10.1128/JB.01499-13
10.1128/JB.01499-14
10.1371/journal.pone.0105506
10.1371/journal.pone.0105507
10.1186/s40793-016-0190-6
10.1186/s40793-016-0190-7
Unpublished
Unpublished
Unpublished
10.1007/s00253-015-6936-z
10.1007/s00253-015-6936-z
10.1007/s00253-015-6936-z
10.1007/s00253-015-6936-z
10.1073/pnas.0607048103
10.1128/JB.00555-12
10.1128/JB.00555-13
10.1099/mgen.0.000363
10.1128/MRA.00849-18
10.1128/MRA.00849-19
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Table S4. 3. The amino acid sequences of had, hkd and facd genes retrieved from Uniprot and
JGI IMG database. The dehalogenation of the indicated substrate was experimentally verified.
Sequence ID
Gene (JGI IMG ID
Name or Uniprot
ID)

Host
Pseudomonas sp. strain
273
Moraxella sp. B
Moraxella sp. B
Rhodopseudomonas
palustris CGA009

Substrate

had

2814128232

facD
had

Q01398
Q01399

facD

Q6NAM1

had

Q0SK70

had

Q2IG66

had

Q6N6V7

had

Q6N251

had

Q8XZN3

Ralstonia solanacearum

chloroacetate

facD

Q8Z0Q1

Nostoc sp. PCC 7120

fluoroacetate

had

Q9I5C9

Pseudomonas aeruginosa

chloroacetate

had

Q9RKI6

Streptomyces coelicolor

chloroacetate

had

Q12G50

Polaromonas sp. JS666

fluoroacetate

hkd

Q28P25

Jannaschia sp. CCS1

chloroalkane

had

Q28RT7

Jannaschia sp. CCS1

chloroacetate

hkd

Q82E37

Streptomyces avermitilis

chloroalkane

had

Q82PY4

Streptomyces avermitilis

chloroacetate

had

Q92RC4

Sinorhizobium meliloti

chloroacetate

had

Q122Z0

Polaromonas sp. JS666

fluoroacetate

facD

Q123C8

Polaromonas sp. JS666

fluoroacetate

facD

Q479B8

Dechloromonas
aromatica RCB

fluoroacetate

Rhodococcus jostii RHA1
Anaeromyxobacter
dehalogenans 2CP-C
Rhodopseudomonas
palustris
Rhodopseudomonas
palustris

Reference (DOI)

Unknown

Unpublished

fluoroacetate
chloroacetate

10.1099/00221287-138-7-1317
10.1099/00221287-138-7-1317
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x
10.1111/j.17517915.2009.00155.x

fluoroacetate
fluoroacetate
fluoroacetate
chloroacetate
chloroacetate
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Chapter 5. Summary and Conclusion
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Fluorinated organics have been produced for various industrial, military, medical and
agrochemical applications, which now emerge as the environmental pollutants demonstrating
persistence in the environment and adverse health impact on human. The major sources of the
fluorinated organics in the environment are associated with the anthropogenic activities including
the application of the aqueous film-forming foams (AFFF) comprising the per- and polyfluorinated
alkyl substances (PFAS) as the major component and commingled with fluoroalkanes. The high
energy cost and extensive waste generation have restricted the treatment of fluorinated organics in
contaminated sites using physical-chemical approaches. Bioremediation is a cost-effective and
environment-friendly strategy for removing pollutants in situ. However, the high bond dissociation
energy of the C-F bonds and the strong electronegativity of fluorine both hinder the microbial
degradation of fluorinated organics. The success in isolating and characterizing microorganism
capable of breaking C-F bonds will advance the application potential of bioremediation. Although
substantially less literatures reported the microbial defluorination compared to the dechlorination
and debromination, the long history of naturally occurring fluorinated organics produced from the
volcanic, botanic and microbial activities suggests microorganisms have had ample time to evolve
enzyme system for breaking C-F bonds.
Pseudomonas sp. strain 273 was initially isolated from the soil with the capability of
degrading C5 to C12 α, ω-dichloroalkanes with resultant release of chloride. Chapter 2
demonstrated that strain 273 can utilize the mono-fluoroalkanes with carbon chain length between
C7 to C10, and C14 and 1,10-difluorodecane (DFD) as the sole carbon source for growth
accompanied with fluoride release. Mass balance study determined that the majority of fluorine
(>90%) in 1-fluorodecane (FD) and DFD could be recovered as inorganic fluoride indicating the
enzyme system in strain 273 can efficiently break C-F bond in fluoroalkanes. Strain 273 can grow
with the decanoate under anoxic condition using the nitrate, nitrite or nitrous oxide as the electron
acceptor. However, the growth with FD and fluoride release only occurred when oxygen supplied
as the electron acceptor indicating the oxygenase in strain 273 may involve in the degradation and
defluorination of fluoroalkane(s). The detection of fluoro-hexanoate in both cultures receiving FD
or DFD indicated the oxygenase can attack terminal methyl or fluoromethyl group to initiate
fluoroalkane oxidation. Strain 273 can not utilize mono-fluoroacetate (MFA) as the sole carbon
source and the incomplete defluorination on MFA was observed in the presence of decane as the
primary substrate which suggest the presence of enzyme system in strain 273 capable of
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defluorinating fluorinated fatty acid. Lower growth yields were determined in cultures receiving
the fluorinated substrates (i.e., FD or DFD) compared to the decane. Observations in chapter 2
revealed novel defluorination capability to medium-chain fluoroalkanes by strain 273 with the
implications for the biological treatment of fluorinated chemicals.
The precise mass balance experiment determined that not all the fluorine in fluoroalkanes
could be recovered as inorganic fluoride indicating the possible unknown fluorine sink in strain
273 cells and triggered the researches in chapter 3. Besides short-chain fluorinated fatty acids
identified as the degradation products in -oxidation, the long-chain fluorinated fatty acids were
identified as the assimilation products in fatty acid methyl esters (FAMEs) analysis. The
lipidomics analysis indicated that 8% and 91% of glycerophospholipids in cells grown with FD
and DFD, respectively, were fluorinated. The tandem mass analysis demonstrated that the fluorine
could be covalently incorporated into the fatty acid tails in glycerophospholipids which unraveled
the unrecognized sink for organofluorine. The fluoroalkane metabolism pathway in strain 273 was
composed by the collection of metabolites identified in both FAMEs and lipidomics analyses. The
fluoroalkane was firstly oxidized and channeled to -oxidation in generating short-chain
fluorinated fatty acids. The majority of the fatty acids were mineralized to carbon dioxide and
fluoride. A meager portion of fluorofatty acids were channeled to fatty acid synthesis in producing
long-chain fluorinated fatty acids which then be incorporated into glycerophospholipids. The
amount of fluorine assimilated was estimated as 5 × 10-8 nmol of F per cell of strain 273. Although
the fluorine mass balance was not closed even considering the fluorine assimilation into the
glycerophospholipids, the fluorine assimilation in microorganisms may significantly impact the
fate and transport behavior of fluorinated organics in the environment.
To investigate the enzyme(s) involved in defluorination of fluoroalkanes, chapter 4 applied
the genomic and comparative transcriptomic approaches. Three alkane 1-monoxoygenase (alkB)
genes present in strain 273 genome while only one of alkB (Gene ID: 2814128504) was
upregulated in the culture grown with decane and DFD, compared to acetate. The resting cell
experiment in Chapter 2 determined that DFD was immediately utilized by the decane grown cells,
without a lag phase. These observations indicate that the same AlkB (2814128504) initiated the
oxidation of both decane and DFD, which consequently defluorinated one terminal fluoromethyl
group in the case of DFD. The gene expression level of alkB genes determined by transcriptomic
sequencing was verified by the quantitative reverse transcription polymerase chain reaction (qRT-
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PCR) demonstrating consensus expression pattern. The co-expression of a gene (2814128505)
encoding ferredoxin reductase (fer2) adjacent to alkB (2814128504) was also determined. One (S)2-haloacid dehalogenase (had) gene (2814128232) was upregulated in cells grown with DFD
which might involve in the defluorination of ω-fluorofatty acids generated in DFD metabolism.
These transcriptional evidences will advance the understandings of enzymes capable of
defluorinating fluoroalkane and fluorofatty acids, and will assist in establishing strategy for
biodegradation, remediation of fluorinated organics.
The fluoroalkanes are proven to be susceptible to biodegradation in this study. The
defluorination capability in strain 273 confers the application potential for the bioaugmentation in
fluorinated chemicals polluted sites, especially for fluoroalkanes. The overlooked anabolic route
in assimilating fluorine into lipids is unraveled as a new mechanism of bioaccumulation which
will broaden the understandings of the fluorinated chemicals fate, transport behavior in the
environment and the biomagnification potential on the food chain. The collection of evidence from
metabolomics, genomics and transcriptomics analyses synergistically illustrate the detailed
fluoroalkane metabolism pathway in strain 273. The investigation of fluoroalkane metabolism
pathway and the identification of associated enzymes in strain 273 will benefit both developing
the bioremediation strategy for fluorinated pollutants and the drug design for fluorinated medicines.
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